| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.968 | 0.003 | 0.968 | Immunomodulator | 0.779 0.005 DBMET00019 0.906 0.004 DBMET00020 0.8 0.004 DBMET01076 0.279 0.095 DBMET01146 | ||
| 0.932 | 0.002 | 0.958 | DNA damaging | 0.958 0.001 DBMET00019 0.898 0.002 DBMET00020 0.243 0.084 DBMET00023 0.87 0.003 DBMET01076 0.876 0.003 DBMET00658 0.93 0.002 DBMET01088 0.947 0.002 DBMET01123 0.804 0.004 DBMET01147 0.608 0.008 DBMET01125 0.257 0.077 DBMET01146 | DBMET00019 | |
| 0.899 | 0.001 | 0.951 | Alkylator | 0.951 0.001 DBMET00019 0.862 0.001 DBMET00020 0.232 0.019 DBMET00023 0.748 0.002 DBMET01076 0.831 0.002 DBMET00658 0.875 0.001 DBMET01088 0.892 0.001 DBMET01123 0.162 0.041 DBMET01126 0.836 0.002 DBMET01147 0.459 0.005 DBMET01125 0.159 0.042 DBMET01146 | DBMET00019 | |
| 0.86 | 0.002 | 0.86 | P-glycoprotein inhibitor | 0.64 0.004 DBMET00019 0.658 0.004 DBMET00020 0.692 0.004 DBMET01076 0.161 0.1 DBMET01125 | ||
| 0.86 | 0.01 | 0.86 | Apoptosis agonist | 0.646 0.04 DBMET00019 0.545 0.061 DBMET00020 0.249 0.215 DBMET00023 0.619 0.045 DBMET01076 0.492 0.077 DBMET00658 0.542 0.062 DBMET01088 0.58 0.054 DBMET01123 0.675 0.035 DBMET01126 0.42 0.104 DBMET01147 0.541 0.063 DBMET01125 0.586 0.052 DBMET01146 | ||
| 0.835 | 0.003 | 0.841 | Immunosuppressant | 0.836 0.003 DBMET00019 0.841 0.003 DBMET00020 0.764 0.004 DBMET01076 0.363 0.08 DBMET00658 0.405 0.06 DBMET01088 0.412 0.058 DBMET01123 0.285 0.125 DBMET01126 0.451 0.047 DBMET01147 0.4 0.063 DBMET01125 0.414 0.058 DBMET01146 | DBMET00020 | |
| 0.811 | 0.003 | 0.811 | DNA synthesis inhibitor | 0.808 0.003 DBMET00019 0.743 0.004 DBMET00020 0.431 0.018 DBMET00023 0.677 0.005 DBMET01076 0.354 0.029 DBMET00658 0.389 0.023 DBMET01088 0.377 0.025 DBMET01123 0.369 0.026 DBMET01126 0.366 0.027 DBMET01147 0.447 0.017 DBMET01125 0.367 0.027 DBMET01146 | ||
| 0.786 | 0.005 | 0.786 | Angiogenesis inhibitor | 0.247 0.125 DBMET00019 0.219 0.149 DBMET00020 0.326 0.081 DBMET01076 0.302 0.091 DBMET01126 0.266 0.112 DBMET01146 | ||
| 0.642 | 0.006 | 0.642 | Antiamyloidogenic | 0.181 0.113 DBMET00020 0.241 0.075 DBMET01076 | ||
| 0.574 | 0.02 | 0.574 | Immunostimulant | 0.437 0.04 DBMET00019 0.387 0.053 DBMET00020 0.21 0.114 DBMET00023 0.44 0.039 DBMET01076 0.196 0.123 DBMET01088 0.337 0.068 DBMET01126 0.228 0.105 DBMET01125 0.342 0.067 DBMET01146 | ||
| 0.39 | 0.004 | 0.995 | ErbB-2 antagonist | 0.135 0.023 DBMET00019 0.091 0.04 DBMET00020 0.183 0.011 DBMET01076 0.989 0.002 DBMET00658 0.975 0.002 DBMET01088 0.995 0.002 DBMET01123 0.981 0.002 DBMET01147 0.15 0.019 DBMET01125 | DBMET01123 | |
| 0.315 | 0.003 | 0.315 | Bcl2 antagonist | 0.171 0.005 DBMET00019 0.19 0.004 DBMET00020 0.203 0.004 DBMET01076 | ||
| 0.262 | 0.013 | 0.654 | Epidermal growth factor receptor kinase inhibitor | 0.132 0.061 DBMET01076 0.564 0.004 DBMET00658 0.473 0.005 DBMET01088 0.654 0.004 DBMET01123 0.166 0.039 DBMET01126 0.472 0.005 DBMET01147 0.137 0.058 DBMET01125 0.171 0.037 DBMET01146 | DBMET01123 | |
| 0.305 | 0.211 | 0.757 | Antiinflammatory | 0.353 0.17 DBMET01126 0.757 0.021 DBMET01146 | DBMET01146 | |
| 0.079 | 0.029 | 0.241 | Carbamoyl phosphate synthetase inhibitor | 0.091 0.023 DBMET00019 0.079 0.029 DBMET00020 0.237 0.006 DBMET00023 0.085 0.026 DBMET01076 0.083 0.027 DBMET00658 0.231 0.006 DBMET01088 0.155 0.011 DBMET01123 0.109 0.018 DBMET01126 0.157 0.01 DBMET01147 0.228 0.006 DBMET01125 0.241 0.006 DBMET01146 | DBMET01146 | |
| 0.09 | 0.06 | 0.546 | Triose-phosphate isomerase inhibitor | 0.081 0.074 DBMET00019 0.09 0.06 DBMET00020 0.546 0.002 DBMET00023 0.099 0.049 DBMET01076 0.174 0.015 DBMET00658 0.272 0.006 DBMET01088 0.17 0.015 DBMET01123 0.402 0.003 DBMET01126 0.195 0.011 DBMET01147 0.293 0.005 DBMET01125 0.466 0.003 DBMET01146 | DBMET00023 | |
| 0.066 | 0.059 | 0.175 | Aminopeptidase I inhibitor | 0.066 0.059 DBMET00020 0.141 0.014 DBMET00023 0.12 0.019 DBMET01088 0.089 0.035 DBMET01123 0.082 0.04 DBMET01126 0.118 0.02 DBMET01147 0.175 0.009 DBMET01125 0.154 0.012 DBMET01146 | DBMET01125 | |
| 0.086 | 0.079 | 0.461 | UDP-glucose 4-epimerase inhibitor | 0.102 0.058 DBMET00019 0.086 0.079 DBMET00020 0.461 0.004 DBMET00023 0.105 0.055 DBMET01076 0.144 0.031 DBMET00658 0.108 0.053 DBMET01088 0.129 0.038 DBMET01123 0.33 0.009 DBMET01126 0.186 0.02 DBMET01147 0.31 0.01 DBMET01125 0.237 0.014 DBMET01146 | DBMET00023 | |
| 0.065 | 0.068 | 0.469 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.116 0.03 DBMET00023 0.314 0.004 DBMET00658 0.447 0.003 DBMET01088 0.469 0.003 DBMET01123 0.453 0.003 DBMET01147 0.128 0.026 DBMET01125 0.09 0.044 DBMET01146 | DBMET01123 | |
| 0.033 | 0.054 | 0.128 | Antimetabolite | 0.056 0.028 DBMET00023 0.041 0.039 DBMET00658 0.082 0.019 DBMET01088 0.061 0.025 DBMET01123 0.051 0.03 DBMET01126 0.051 0.031 DBMET01147 0.12 0.014 DBMET01125 0.128 0.013 DBMET01146 | DBMET01146 | |
| 0.015 | 0.036 | 0.078 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.067 0.006 DBMET00023 0.035 0.014 DBMET00658 0.032 0.016 DBMET01088 0.046 0.01 DBMET01123 0.041 0.012 DBMET01126 0.039 0.012 DBMET01147 0.078 0.005 DBMET01125 0.034 0.015 DBMET01146 | DBMET01125 | |
| 0.057 | 0.084 | 0.509 | Glutamate dehydrogenase inhibitor | 0.212 0.009 DBMET00023 0.169 0.013 DBMET01088 0.085 0.04 DBMET01123 0.175 0.012 DBMET01126 0.127 0.021 DBMET01147 0.203 0.01 DBMET01125 0.509 0.003 DBMET01146 | DBMET01146 | |
| 0.012 | 0.049 | 0.029 | Purinergic P2X agonist | 0.029 0.018 DBMET01147 | DBMET01147 | |
| 0.033 | 0.08 | 0.171 | Glucose-6-phosphate isomerase inhibitor | 0.117 0.004 DBMET00023 0.051 0.028 DBMET00658 0.067 0.014 DBMET01088 0.052 0.027 DBMET01123 0.127 0.003 DBMET01126 0.051 0.028 DBMET01147 0.061 0.018 DBMET01125 0.171 0.002 DBMET01146 | DBMET01146 | |
| 0.025 | 0.078 | 0.092 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 DBMET00023 0.047 0.043 DBMET01088 0.05 0.041 DBMET01126 0.069 0.029 DBMET01125 0.092 0.021 DBMET01146 | DBMET01146 | |
| 0.024 | 0.078 | 0.092 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET00023 0.048 0.044 DBMET01088 0.049 0.043 DBMET01126 0.071 0.031 DBMET01125 0.092 0.023 DBMET01146 | DBMET01146 | |
| 0.218 | 0.273 | 0.575 | MAP kinase 1 inhibitor | 0.575 0.027 DBMET00019 | DBMET00019 | |
| 0.101 | 0.157 | 0.253 | Arachidonic acid antagonist | 0.226 0.014 DBMET00023 0.177 0.057 DBMET01088 0.159 0.078 DBMET01123 0.209 0.025 DBMET01126 0.158 0.079 DBMET01147 0.214 0.021 DBMET01125 0.253 0.005 DBMET01146 | DBMET01146 | |
| 0.074 | 0.132 | 0.41 | GABA C receptor antagonist | 0.149 0.03 DBMET00023 0.257 0.006 DBMET01126 0.125 0.048 DBMET01147 0.208 0.011 DBMET01125 0.41 0.003 DBMET01146 | DBMET01146 | |
| 0.077 | 0.14 | 0.322 | Bone formation stimulant | 0.146 0.062 DBMET01088 0.168 0.047 DBMET01123 0.156 0.054 DBMET01126 0.322 0.015 DBMET01147 0.122 0.084 DBMET01146 | DBMET01147 | |
| 0.119 | 0.184 | 0.724 | Succinate dehydrogenase inhibitor | 0.564 0.003 DBMET00023 0.189 0.059 DBMET00658 0.249 0.023 DBMET01088 0.188 0.059 DBMET01123 0.471 0.003 DBMET01126 0.168 0.083 DBMET01147 0.32 0.008 DBMET01125 0.724 0.002 DBMET01146 | DBMET01146 | |
| 0.064 | 0.13 | 0.742 | GABA C receptor agonist | 0.283 0.01 DBMET00023 0.164 0.029 DBMET01088 0.355 0.007 DBMET01126 0.11 0.057 DBMET01147 0.374 0.006 DBMET01125 0.742 0.002 DBMET01146 | DBMET01146 | |
| 0.058 | 0.126 | 0.32 | Glutathione S-transferase inhibitor | 0.125 0.02 DBMET00023 0.212 0.005 DBMET00658 0.311 0.003 DBMET01088 0.32 0.003 DBMET01123 0.13 0.018 DBMET01126 0.209 0.005 DBMET01147 0.161 0.01 DBMET01125 0.245 0.004 DBMET01146 | DBMET01123 | |
| 0.061 | 0.136 | 0.246 | NADH dehydrogenase inhibitor | 0.148 0.018 DBMET00023 0.085 0.064 DBMET01088 0.08 0.074 DBMET01123 0.134 0.022 DBMET01126 0.112 0.033 DBMET01147 0.156 0.016 DBMET01125 0.246 0.008 DBMET01146 | DBMET01146 | |
| 0.003 | 0.099 | 0.022 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET01126 0.022 0.005 DBMET01146 | DBMET01146 | |
| 0.007 | 0.106 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 DBMET01146 | DBMET01146 | |
| 0.011 | 0.11 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00023 0.023 0.005 DBMET01126 0.02 0.009 DBMET01125 0.024 0.004 DBMET01146 | DBMET01146 | |
| 0.023 | 0.123 | 0.233 | Acyl-CoA dehydrogenase inhibitor | 0.096 0.017 DBMET00023 0.055 0.037 DBMET01088 0.153 0.009 DBMET01126 0.063 0.031 DBMET01147 0.123 0.012 DBMET01125 0.233 0.004 DBMET01146 | DBMET01146 | |
| 0.046 | 0.151 | 0.24 | Aminopeptidase B inhibitor | 0.24 0.014 DBMET00023 0.082 0.08 DBMET00658 0.143 0.041 DBMET01088 0.095 0.068 DBMET01123 0.155 0.035 DBMET01126 0.148 0.039 DBMET01147 0.217 0.018 DBMET01125 0.196 0.022 DBMET01146 | DBMET00023 | |
| 0.009 | 0.117 | 0.027 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00023 0.027 0.004 DBMET01125 0.019 0.013 DBMET01146 | DBMET01125 | |
| 0.065 | 0.18 | 0.713 | Alpha-N-acetylglucosaminidase inhibitor | 0.655 0.003 DBMET00023 0.106 0.093 DBMET00658 0.133 0.066 DBMET01088 0.105 0.095 DBMET01123 0.638 0.004 DBMET01126 0.11 0.088 DBMET01147 0.414 0.008 DBMET01125 0.713 0.003 DBMET01146 | DBMET01146 | |
| 0.025 | 0.142 | 0.394 | Phosphofructokinase-1 inhibitor | 0.211 0.01 DBMET00023 0.059 0.058 DBMET00658 0.109 0.029 DBMET01088 0.06 0.057 DBMET01123 0.291 0.006 DBMET01126 0.064 0.053 DBMET01147 0.103 0.031 DBMET01125 0.394 0.003 DBMET01146 | DBMET01146 | |
| 0.049 | 0.17 | 0.258 | Prolactin inhibitor | 0.197 0.009 DBMET00023 0.182 0.012 DBMET01126 0.258 0.004 DBMET01125 0.199 0.009 DBMET01146 | DBMET01125 | |
| 0.017 | 0.142 | 0.101 | Membrane dipeptidase inhibitor | 0.049 0.016 DBMET00023 0.053 0.014 DBMET01126 0.067 0.008 DBMET01125 0.101 0.004 DBMET01146 | DBMET01146 | |
| 0.011 | 0.14 | 0.041 | Vanilloid 2 agonist | 0.024 0.021 DBMET00023 0.032 0.008 DBMET01126 0.025 0.018 DBMET01125 0.041 0.004 DBMET01146 | DBMET01146 | |
| 0.052 | 0.183 | 0.165 | Anabolic | 0.144 0.021 DBMET00023 0.146 0.02 DBMET01126 0.087 0.084 DBMET01147 0.14 0.024 DBMET01125 0.165 0.011 DBMET01146 | DBMET01146 | |
| 0.014 | 0.145 | 0.258 | Ornithine carbamoyltransferase inhibitor | 0.104 0.015 DBMET00023 0.052 0.038 DBMET01088 0.051 0.038 DBMET01123 0.192 0.007 DBMET01126 0.092 0.018 DBMET01125 0.258 0.005 DBMET01146 | DBMET01146 | |
| 0.01 | 0.144 | 0.345 | Fumarate hydratase inhibitor | 0.047 0.015 DBMET00023 0.036 0.022 DBMET01088 0.055 0.012 DBMET01126 0.039 0.02 DBMET01125 0.345 0.002 DBMET01146 | DBMET01146 | |
| 0.002 | 0.139 | 0.035 | Glutamate (mGluR6) agonist | 0.035 0.003 DBMET01146 | DBMET01146 | |
| 0.039 | 0.177 | 0.072 | Lipocortins synthesis agonist | 0.072 0.019 DBMET00023 0.064 0.029 DBMET01125 | DBMET00023 | |
| 0.006 | 0.144 | 0.022 | Telomerase stimulant | 0.017 0.013 DBMET00023 0.016 0.015 DBMET01126 0.022 0.006 DBMET01146 | DBMET01146 | |
| 0.023 | 0.17 | 0.222 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.15 0.009 DBMET00023 0.222 0.006 DBMET01126 0.055 0.041 DBMET01147 0.076 0.022 DBMET01125 0.205 0.006 DBMET01146 | DBMET01126 | |
| 0.01 | 0.159 | 0.04 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET01126 0.025 0.017 DBMET01125 0.04 0.005 DBMET01146 | DBMET01146 | |
| 0.021 | 0.172 | 0.079 | Alpha-mannosidase inhibitor | 0.079 0.012 DBMET00023 0.075 0.014 DBMET01126 0.066 0.02 DBMET01125 0.078 0.012 DBMET01146 | DBMET00023 | |
| 0.139 | 0.291 | 0.44 | Tyrosine 3 hydroxylase inhibitor | 0.294 0.036 DBMET00023 0.2 0.135 DBMET01088 0.295 0.036 DBMET01126 0.346 0.017 DBMET01125 0.44 0.005 DBMET01146 | DBMET01146 | |
| 0.061 | 0.216 | 0.382 | Adenylate kinase inhibitor | 0.263 0.009 DBMET00023 0.092 0.082 DBMET00658 0.12 0.043 DBMET01088 0.355 0.004 DBMET01126 0.112 0.052 DBMET01147 0.159 0.023 DBMET01125 0.382 0.004 DBMET01146 | DBMET01146 | |
| 0.019 | 0.181 | 0.113 | Glutamate (mGluR8) agonist | 0.047 0.014 DBMET00023 0.051 0.011 DBMET01126 0.04 0.023 DBMET01125 0.113 0.003 DBMET01146 | DBMET01146 | |
| 0.017 | 0.19 | 0.198 | Argininosuccinate synthase inhibitor | 0.176 0.009 DBMET00023 0.051 0.046 DBMET01088 0.168 0.01 DBMET01126 0.08 0.025 DBMET01125 0.198 0.008 DBMET01146 | DBMET01146 | |
| 0.039 | 0.213 | 0.14 | Glutamate (mGluR6) antagonist | 0.079 0.026 DBMET00023 0.066 0.048 DBMET01088 0.08 0.024 DBMET01126 0.072 0.036 DBMET01125 0.14 0.004 DBMET01146 | DBMET01146 | |
| 0.012 | 0.19 | 0.059 | Dopamine D5 agonist | 0.042 0.025 DBMET00023 0.039 0.029 DBMET01126 0.059 0.012 DBMET01125 0.049 0.018 DBMET01146 | DBMET01125 | |
| 0.013 | 0.203 | 0.067 | Mannosidase inhibitor | 0.066 0.014 DBMET00023 0.063 0.015 DBMET01126 0.053 0.023 DBMET01125 0.067 0.013 DBMET01146 | DBMET01146 | |
| 0.131 | 0.323 | 0.276 | 5 Hydroxytryptamine 3E antagonist | 0.226 0.031 DBMET00023 0.234 0.025 DBMET01126 0.276 0.008 DBMET01125 0.187 0.088 DBMET01146 | DBMET01125 | |
| 0.036 | 0.243 | 0.2 | Creatine kinase inhibitor | 0.13 0.034 DBMET00023 0.117 0.043 DBMET01126 0.135 0.031 DBMET01125 0.2 0.01 DBMET01146 | DBMET01146 | |
| 0.043 | 0.254 | 0.336 | GABA C receptor rho-1 antagonist | 0.124 0.036 DBMET00023 0.232 0.005 DBMET01126 0.099 0.063 DBMET01147 0.173 0.014 DBMET01125 0.336 0.003 DBMET01146 | DBMET01146 | |
| 0.016 | 0.228 | 0.335 | Biliverdin reductase inhibitor | 0.096 0.02 DBMET00023 0.055 0.046 DBMET01088 0.161 0.008 DBMET01126 0.082 0.025 DBMET01125 0.335 0.003 DBMET01146 | DBMET01146 | |
| 0.003 | 0.215 | 0.015 | Melatonin 2 antagonist | 0.015 0.005 DBMET01125 | DBMET01125 | |
| 0.003 | 0.216 | 0.031 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 DBMET00023 0.016 0.013 DBMET01126 0.018 0.01 DBMET01125 0.031 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.216 | 0.031 | Carbonic anhydrase X inhibitor | 0.017 0.011 DBMET00023 0.016 0.013 DBMET01126 0.018 0.01 DBMET01125 0.031 0.004 DBMET01146 | DBMET01146 | |
| 0.104 | 0.322 | 0.192 | Ca2+-transporting ATPase inhibitor | 0.165 0.018 DBMET00023 0.17 0.013 DBMET01126 0.156 0.03 DBMET01125 0.192 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.225 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 DBMET01146 | DBMET01146 | |
| 0.067 | 0.298 | 0.302 | Hepatoprotectant | 0.164 0.096 DBMET01126 0.302 0.029 DBMET01146 | DBMET01146 | |
| 0.008 | 0.24 | 0.065 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET01126 0.065 0.008 DBMET01146 | DBMET01146 | |
| 0.019 | 0.257 | 0.567 | Porphobilinogen synthase inhibitor | 0.153 0.02 DBMET00023 0.065 0.061 DBMET01088 0.241 0.008 DBMET01126 0.118 0.029 DBMET01125 0.567 0.003 DBMET01146 | DBMET01146 | |
| 0.006 | 0.246 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 DBMET01125 | DBMET01125 | |
| 0.008 | 0.25 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.035 DBMET00023 0.044 0.033 DBMET01125 | DBMET01125 | |
| 0.005 | 0.25 | 0.043 | Lysine carboxypeptidase inhibitor | 0.026 0.019 DBMET01125 0.043 0.009 DBMET01146 | DBMET01146 | |
| 0.049 | 0.3 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 DBMET01125 0.098 0.064 DBMET01146 | DBMET01125 | |
| 0.001 | 0.256 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DBMET00023 0.007 0.005 DBMET01125 | DBMET01125 | |
| 0.005 | 0.266 | 0.042 | Phosphoglycerate kinase inhibitor | 0.032 0.028 DBMET01125 0.042 0.018 DBMET01146 | DBMET01146 | |
| 0.038 | 0.3 | 0.347 | Thioredoxin inhibitor | 0.179 0.011 DBMET00023 0.347 0.002 DBMET01125 0.096 0.053 DBMET01146 | DBMET01125 | |
| 0.018 | 0.282 | 0.459 | Glutamate decarboxylase inhibitor | 0.168 0.01 DBMET00023 0.067 0.059 DBMET01088 0.245 0.004 DBMET01126 0.093 0.034 DBMET01125 0.459 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.267 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 DBMET01146 | DBMET01146 | |
| 0.008 | 0.273 | 0.039 | Acid ceramidase inhibitor | 0.027 0.015 DBMET00023 0.039 0.004 DBMET01125 | DBMET01125 | |
| 0.016 | 0.284 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 DBMET00023 0.123 0.015 DBMET01126 0.07 0.06 DBMET01125 0.116 0.019 DBMET01146 | DBMET01126 | |
| 0.098 | 0.368 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.213 0.082 DBMET00023 0.235 0.06 DBMET01126 0.196 0.105 DBMET01125 0.274 0.038 DBMET01146 | DBMET01146 | |
| 0.05 | 0.323 | 0.513 | Anesthetic general | 0.295 0.034 DBMET00023 0.24 0.055 DBMET01088 0.168 0.096 DBMET01123 0.266 0.044 DBMET01126 0.293 0.035 DBMET01125 0.513 0.007 DBMET01146 | DBMET01146 | |
| 0.067 | 0.341 | 0.187 | Vanilloid 1 agonist | 0.12 0.089 DBMET01123 0.144 0.045 DBMET01126 0.112 0.107 DBMET01125 0.187 0.016 DBMET01146 | DBMET01146 | |
| 0.036 | 0.313 | 0.39 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.146 0.028 DBMET00023 0.178 0.02 DBMET01126 0.129 0.034 DBMET01125 0.39 0.004 DBMET01146 | DBMET01146 | |
| 0.007 | 0.286 | 0.108 | Carbonic anhydrase VB inhibitor | 0.057 0.038 DBMET01125 0.108 0.014 DBMET01146 | DBMET01146 | |
| 0.023 | 0.303 | 0.302 | GABA aminotransferase inhibitor | 0.136 0.011 DBMET00023 0.144 0.009 DBMET01126 0.162 0.006 DBMET01125 0.302 0.003 DBMET01146 | DBMET01146 | |
| 0.004 | 0.288 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 DBMET00023 0.022 0.016 DBMET01125 0.028 0.007 DBMET01146 | DBMET01146 | |
| 0.015 | 0.299 | 0.354 | Aconitate hydratase inhibitor | 0.078 0.014 DBMET00023 0.097 0.009 DBMET01126 0.063 0.023 DBMET01125 0.354 0.002 DBMET01146 | DBMET01146 | |
| 0.007 | 0.292 | 0.039 | Purinergic P2Y15 antagonist | 0.032 0.014 DBMET00023 0.029 0.02 DBMET01126 0.039 0.007 DBMET01125 0.029 0.018 DBMET01146 | DBMET01125 | |
| 0.015 | 0.302 | 0.081 | Androgen agonist | 0.067 0.033 DBMET00023 0.055 0.049 DBMET01126 0.081 0.023 DBMET01125 0.074 0.028 DBMET01146 | DBMET01125 | |
| 0.026 | 0.314 | 0.18 | Ornithine decarboxylase inhibitor | 0.116 0.028 DBMET00023 0.151 0.011 DBMET01126 0.11 0.034 DBMET01125 0.18 0.006 DBMET01146 | DBMET01146 | |
| 0.01 | 0.3 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 DBMET01146 | DBMET01146 | |
| 0.008 | 0.299 | 0.08 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET00023 0.046 0.032 DBMET01126 0.06 0.017 DBMET01125 0.08 0.007 DBMET01146 | DBMET01146 | |
| 0.097 | 0.389 | 0.362 | Vasodilator, coronary | 0.276 0.109 DBMET00023 0.237 0.148 DBMET01126 0.362 0.05 DBMET01125 0.305 0.083 DBMET01146 | DBMET01125 | |
| 0.011 | 0.307 | 0.525 | Alcohol oxidase inhibitor | 0.394 0.004 DBMET00023 0.386 0.004 DBMET01126 0.088 0.021 DBMET01125 0.525 0.004 DBMET01146 | DBMET01146 | |
| 0.015 | 0.311 | 0.067 | HCV NS3/NS4A protease inhibitor | 0.067 0.016 DBMET01126 0.066 0.017 DBMET01146 | DBMET01126 | |
| 0.039 | 0.335 | 0.222 | Microtubule formation inhibitor | 0.17 0.029 DBMET00023 0.191 0.022 DBMET01126 0.18 0.025 DBMET01125 0.222 0.015 DBMET01146 | DBMET01146 | |
| 0.004 | 0.303 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 DBMET01146 | DBMET01146 | |
| 0.006 | 0.306 | 0.058 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET01126 0.058 0.004 DBMET01146 | DBMET01146 | |
| 0.028 | 0.329 | 0.285 | Cystathionine beta-synthase inhibitor | 0.259 0.014 DBMET00023 0.135 0.048 DBMET01126 0.21 0.022 DBMET01125 0.285 0.011 DBMET01146 | DBMET01146 | |
| 0.028 | 0.334 | 0.091 | Sphingomyelinase inhibitor | 0.091 0.071 DBMET01125 0.088 0.075 DBMET01146 | DBMET01125 | |
| 0.017 | 0.326 | 0.075 | Dopamine beta hydroxylase inhibitor | 0.062 0.014 DBMET00023 0.069 0.008 DBMET01126 0.069 0.009 DBMET01125 0.075 0.006 DBMET01146 | DBMET01146 | |
| 0.035 | 0.348 | 0.314 | Amylase inhibitor | 0.314 0.017 DBMET00023 0.27 0.023 DBMET01126 0.162 0.059 DBMET01125 0.271 0.023 DBMET01146 | DBMET00023 | |
| 0.059 | 0.374 | 0.261 | Adenylate cyclase stimulant | 0.142 0.078 DBMET00023 0.201 0.013 DBMET01126 0.171 0.034 DBMET01125 0.261 0.004 DBMET01146 | DBMET01146 | |
| 0.011 | 0.326 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 DBMET00023 0.063 0.018 DBMET01126 0.062 0.019 DBMET01125 0.065 0.016 DBMET01146 | DBMET00023 | |
| 0.021 | 0.342 | 0.145 | Glycine receptor antagonist | 0.082 0.054 DBMET00023 0.117 0.02 DBMET01126 0.094 0.038 DBMET01125 0.145 0.009 DBMET01146 | DBMET01146 | |
| 0.011 | 0.334 | 0.049 | Prolyl endopeptidase inhibitor | 0.049 0.037 DBMET00023 0.047 0.041 DBMET01126 | DBMET00023 | |
| 0.099 | 0.423 | 0.667 | GABA C receptor rho-3 antagonist | 0.477 0.032 DBMET00023 0.646 0.004 DBMET01126 0.556 0.014 DBMET01125 0.667 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.327 | 0.026 | Thromboxane A2 agonist | 0.015 0.013 DBMET00023 0.014 0.013 DBMET01126 0.026 0.004 DBMET01146 | DBMET01146 | |
| 0.008 | 0.334 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET01146 | DBMET01146 | |
| 0.035 | 0.36 | 0.26 | Cathepsin H inhibitor | 0.26 0.013 DBMET00023 0.181 0.029 DBMET01126 0.205 0.021 DBMET01125 0.143 0.051 DBMET01146 | DBMET00023 | |
| 0.021 | 0.347 | 0.102 | Purinergic P2X1 antagonist | 0.077 0.027 DBMET00023 0.071 0.031 DBMET01126 0.056 0.051 DBMET01125 0.102 0.016 DBMET01146 | DBMET01146 | |
| 0.003 | 0.329 | 0.021 | Nicotinic alpha4 receptor agonist | 0.021 0.006 DBMET01126 | DBMET01126 | |
| 0.015 | 0.343 | 0.154 | Kainate receptor agonist | 0.044 0.023 DBMET00023 0.07 0.004 DBMET01126 0.042 0.027 DBMET01125 0.154 0.002 DBMET01146 | DBMET01146 | |
| 0.027 | 0.356 | 0.193 | Glycine receptor agonist | 0.078 0.041 DBMET00023 0.11 0.016 DBMET01126 0.072 0.052 DBMET01125 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.336 | 0.055 | Arginase inhibitor | 0.035 0.027 DBMET01125 0.055 0.012 DBMET01146 | DBMET01146 | |
| 0.004 | 0.34 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET01126 | DBMET01126 | |
| 0.024 | 0.362 | 0.081 | Ryanodine receptor antagonist | 0.063 0.029 DBMET01126 0.059 0.04 DBMET01125 0.081 0.008 DBMET01146 | DBMET01146 | |
| 0.038 | 0.377 | 0.181 | DOPA decarboxylase inhibitor | 0.134 0.032 DBMET00023 0.128 0.037 DBMET01126 0.11 0.058 DBMET01125 0.181 0.01 DBMET01146 | DBMET01146 | |
| 0.007 | 0.347 | 0.08 | GABA uptake inhibitor | 0.044 0.022 DBMET00023 0.068 0.008 DBMET01126 0.08 0.005 DBMET01146 | DBMET01146 | |
| 0.003 | 0.349 | 0.062 | Uridine phosphorylase inhibitor | 0.038 0.013 DBMET01126 0.062 0.005 DBMET01146 | DBMET01146 | |
| 0.005 | 0.352 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 DBMET01126 | DBMET01126 | |
| 0.036 | 0.384 | 0.304 | Thioredoxin reductase inhibitor | 0.202 0.004 DBMET00023 0.128 0.014 DBMET01126 0.304 0.003 DBMET01125 0.08 0.061 DBMET01146 | DBMET01125 | |
| 0.011 | 0.359 | 0.133 | Lysophosphatidic acid 3 receptor antagonist | 0.07 0.015 DBMET01126 0.133 0.003 DBMET01146 | DBMET01146 | |
| 0.015 | 0.363 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.05 0.015 DBMET00023 0.045 0.021 DBMET01126 0.049 0.015 DBMET01125 0.062 0.007 DBMET01146 | DBMET01146 | |
| 0.006 | 0.356 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET01126 0.035 0.004 DBMET01146 | DBMET01146 | |
| 0.019 | 0.37 | 0.156 | Cathepsin G inhibitor | 0.156 0.02 DBMET00023 0.085 0.04 DBMET01126 0.091 0.037 DBMET01125 0.111 0.03 DBMET01146 | DBMET00023 | |
| 0.004 | 0.355 | 0.028 | Nicotinic alpha3beta4 receptor agonist | 0.028 0.024 DBMET01125 | DBMET01125 | |
| 0.06 | 0.413 | 0.375 | Phospholipase C inhibitor | 0.14 0.129 DBMET00023 0.142 0.124 DBMET01088 0.139 0.131 DBMET01123 0.202 0.042 DBMET01126 0.17 0.073 DBMET01125 0.375 0.012 DBMET01146 | DBMET01146 | |
| 0.004 | 0.358 | 0.056 | Geranyltranstransferase inhibitor | 0.048 0.025 DBMET00023 0.056 0.017 DBMET01126 0.055 0.017 DBMET01125 0.053 0.019 DBMET01146 | DBMET01126 | |
| 0.014 | 0.368 | 0.114 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET01125 0.114 0.02 DBMET01146 | DBMET01146 | |
| 0.008 | 0.365 | 0.044 | Toll-Like receptor 2 agonist | 0.038 0.031 DBMET01125 0.044 0.027 DBMET01146 | DBMET01146 | |
| 0.012 | 0.373 | 0.12 | Carbonic anhydrase V inhibitor | 0.12 0.021 DBMET01146 | DBMET01146 | |
| 0.031 | 0.396 | 0.101 | Vanilloid 4 agonist | 0.078 0.045 DBMET00023 0.089 0.027 DBMET01126 0.096 0.02 DBMET01125 0.101 0.016 DBMET01146 | DBMET01146 | |
| 0.049 | 0.415 | 0.349 | GABA C receptor rho-2 antagonist | 0.175 0.046 DBMET00023 0.294 0.006 DBMET01126 0.222 0.019 DBMET01125 0.349 0.004 DBMET01146 | DBMET01146 | |
| 0.078 | 0.444 | 0.557 | 5 Hydroxytryptamine release stimulant | 0.245 0.091 DBMET00023 0.401 0.046 DBMET01126 0.557 0.019 DBMET01125 0.484 0.03 DBMET01146 | DBMET01125 | |
| 0.012 | 0.384 | 0.333 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET00023 0.084 0.04 DBMET01126 0.082 0.041 DBMET01125 0.333 0.005 DBMET01146 | DBMET01146 | |
| 0.004 | 0.377 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET01125 | DBMET01125 | |
| 0.021 | 0.395 | 0.209 | Mucolytic | 0.118 0.057 DBMET01126 0.11 0.065 DBMET01125 0.209 0.011 DBMET01146 | DBMET01146 | |
| 0.109 | 0.484 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.289 0.051 DBMET00023 0.346 0.027 DBMET01126 0.355 0.024 DBMET01125 0.438 0.009 DBMET01146 | DBMET01146 | |
| 0.001 | 0.377 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET01146 | DBMET01146 | |
| 0.009 | 0.386 | 0.048 | Glutamate (mGluR3) agonist | 0.048 0.005 DBMET01146 | DBMET01146 | |
| 0.009 | 0.385 | 0.063 | Histamine H1 receptor agonist | 0.063 0.007 DBMET01125 | DBMET01125 | |
| 0.016 | 0.394 | 0.095 | Phospholipase D inhibitor | 0.068 0.057 DBMET00023 0.072 0.048 DBMET01126 0.095 0.018 DBMET01125 0.091 0.021 DBMET01146 | DBMET01125 | |
| 0.007 | 0.387 | 0.049 | Oxytocin agonist | 0.049 0.025 DBMET01125 | DBMET01125 | |
| 0.032 | 0.412 | 0.243 | Protein kinase stimulant | 0.133 0.081 DBMET01126 0.243 0.028 DBMET01146 | DBMET01146 | |
| 0.001 | 0.381 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01146 | DBMET01146 | |
| 0.02 | 0.405 | 0.046 | Heme oxygenase inhibitor | 0.041 0.04 DBMET00023 0.042 0.031 DBMET01126 0.046 0.021 DBMET01146 | DBMET01146 | |
| 0.051 | 0.439 | 0.174 | DNA repair enzyme inhibitor | 0.132 0.052 DBMET00023 0.174 0.016 DBMET01125 0.118 0.077 DBMET01146 | DBMET01125 | |
| 0.037 | 0.427 | 0.103 | D-Ala-D-Ala ligase inhibitor | 0.085 0.054 DBMET00023 0.079 0.071 DBMET01126 0.088 0.048 DBMET01125 0.103 0.026 DBMET01146 | DBMET01146 | |
| 0.012 | 0.402 | 0.054 | Thymidine kinase inhibitor | 0.04 0.03 DBMET01126 0.039 0.031 DBMET01125 0.054 0.017 DBMET01146 | DBMET01146 | |
| 0.008 | 0.398 | 0.033 | Dipeptidyl peptidase II inhibitor | 0.033 0.022 DBMET01125 | DBMET01125 | |
| 0.032 | 0.424 | 0.114 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 DBMET00023 0.105 0.029 DBMET01126 0.099 0.036 DBMET01125 0.114 0.02 DBMET01146 | DBMET01146 | |
| 0.04 | 0.435 | 0.103 | Estrogen-related receptor beta agonist | 0.083 0.056 DBMET00023 0.082 0.061 DBMET01126 0.097 0.028 DBMET01125 0.103 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.401 | 0.015 | Thromboxane agonist | 0.015 0.005 DBMET01146 | DBMET01146 | |
| 0.011 | 0.412 | 0.317 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.048 DBMET00023 0.107 0.023 DBMET01126 0.085 0.034 DBMET01125 0.317 0.004 DBMET01146 | DBMET01146 | |
| 0.021 | 0.426 | 0.523 | Ferrochelatase inhibitor | 0.248 0.013 DBMET00023 0.331 0.005 DBMET01126 0.237 0.015 DBMET01125 0.523 0.002 DBMET01146 | DBMET01146 | |
| 0.014 | 0.42 | 0.239 | Expectorant | 0.095 0.075 DBMET01126 0.239 0.014 DBMET01146 | DBMET01146 | |
| 0.006 | 0.412 | 0.15 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 DBMET01126 0.15 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.41 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 DBMET01146 | DBMET01146 | |
| 0.006 | 0.417 | 0.019 | Caspase 8 inhibitor | 0.019 0.014 DBMET00023 | DBMET00023 | |
| 0.09 | 0.502 | 0.273 | Nitric-oxide synthase stimulant | 0.223 0.057 DBMET00023 0.204 0.082 DBMET01126 0.273 0.02 DBMET01125 0.231 0.047 DBMET01146 | DBMET01125 | |
| 0.003 | 0.416 | 0.138 | Retinoid X receptor agonist | 0.049 0.018 DBMET01126 0.138 0.003 DBMET01146 | DBMET01146 | |
| 0.014 | 0.43 | 0.073 | Calcium antagonist | 0.073 0.07 DBMET01125 | DBMET01125 | |
| 0.004 | 0.422 | 0.071 | Retinoid X beta receptor antagonist | 0.026 0.006 DBMET01126 0.071 0.002 DBMET01146 | DBMET01146 | |
| 0.006 | 0.424 | 0.026 | Factor XIII inhibitor | 0.026 0.006 DBMET01126 0.022 0.011 DBMET01146 | DBMET01126 | |
| 0.005 | 0.427 | 0.03 | Thyroid hormone agonist | 0.03 0.013 DBMET01146 | DBMET01146 | |
| 0.013 | 0.437 | 0.108 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET00023 0.091 0.021 DBMET01126 0.108 0.009 DBMET01125 0.094 0.018 DBMET01146 | DBMET01125 | |
| 0.002 | 0.433 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DBMET01126 | DBMET01126 | |
| 0.035 | 0.468 | 0.174 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.033 DBMET00023 0.174 0.017 DBMET01125 0.14 0.044 DBMET01146 | DBMET01125 | |
| 0.009 | 0.447 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 DBMET01126 0.026 0.02 DBMET01125 0.03 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.441 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET01126 | DBMET01126 | |
| 0.003 | 0.442 | 0.039 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET00023 0.025 0.012 DBMET01125 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.016 | 0.456 | 0.284 | Cholesterol synthesis inhibitor | 0.128 0.058 DBMET00023 0.187 0.03 DBMET01126 0.284 0.013 DBMET01146 | DBMET01146 | |
| 0.006 | 0.447 | 0.039 | Integrin alpha2beta1 antagonist | 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.02 | 0.462 | 0.164 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 DBMET00023 0.09 0.089 DBMET01126 0.164 0.028 DBMET01125 | DBMET01125 | |
| 0.029 | 0.473 | 0.174 | Toll-Like receptor 4 antagonist | 0.09 0.089 DBMET01126 0.174 0.011 DBMET01146 | DBMET01146 | |
| 0.014 | 0.461 | 0.115 | Alpha 2 adrenoreceptor antagonist | 0.115 0.038 DBMET01125 | DBMET01125 | |
| 0.126 | 0.573 | 0.459 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.456 0.058 DBMET00023 0.436 0.071 DBMET01126 0.459 0.056 DBMET01125 0.388 0.112 DBMET01146 | DBMET01125 | |
| 0.027 | 0.475 | 0.224 | Mannose-6-phosphate isomerase inhibitor | 0.224 0.02 DBMET00023 0.206 0.027 DBMET01126 0.209 0.026 DBMET01146 | DBMET00023 | |
| 0.009 | 0.459 | 0.255 | Catalase inhibitor | 0.167 0.022 DBMET00023 0.177 0.02 DBMET01126 0.071 0.054 DBMET01125 0.255 0.008 DBMET01146 | DBMET01146 | |
| 0.01 | 0.461 | 0.026 | Hedgehog signaling activator | 0.026 0.024 DBMET01125 | DBMET01125 | |
| 0.005 | 0.456 | 0.046 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 DBMET00023 0.046 0.02 DBMET01125 | DBMET01125 | |
| 0.004 | 0.462 | 0.151 | Retinoid X alpha receptor agonist | 0.04 0.02 DBMET01126 0.151 0.003 DBMET01146 | DBMET01146 | |
| 0.007 | 0.466 | 0.058 | Histamine H2 receptor agonist | 0.058 0.015 DBMET01125 | DBMET01125 | |
| 0.02 | 0.481 | 0.467 | Neurotrophic factor | 0.467 0.004 DBMET01126 | DBMET01126 | |
| 0.025 | 0.487 | 0.216 | Toll-Like receptor 2 antagonist | 0.162 0.045 DBMET01126 0.104 0.098 DBMET01125 0.216 0.017 DBMET01146 | DBMET01146 | |
| 0.02 | 0.482 | 0.202 | Keratolytic | 0.07 0.065 DBMET01126 0.202 0.008 DBMET01146 | DBMET01146 | |
| 0.004 | 0.466 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET01125 | DBMET01125 | |
| 0.03 | 0.492 | 0.431 | TRPA1 agonist | 0.235 0.006 DBMET00023 0.431 0.004 DBMET01126 0.151 0.03 DBMET01125 0.209 0.009 DBMET01146 | DBMET01126 | |
| 0.012 | 0.48 | 0.084 | Sphingosine 1-phosphate receptor 1 antagonist | 0.084 0.013 DBMET01125 | DBMET01125 | |
| 0.01 | 0.482 | 0.048 | Squalene epoxidase inhibitor | 0.047 0.04 DBMET01126 0.048 0.038 DBMET01125 0.046 0.042 DBMET01146 | DBMET01125 | |
| 0.009 | 0.484 | 0.136 | Sphingosine 1-phosphate receptor 4 agonist | 0.061 0.053 DBMET01126 0.136 0.011 DBMET01146 | DBMET01146 | |
| 0.015 | 0.495 | 0.099 | Histamine N-methyltransferase inhibitor | 0.099 0.047 DBMET01125 | DBMET01125 | |
| 0.005 | 0.485 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 DBMET00023 | DBMET00023 | |
| 0.01 | 0.495 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.066 0.029 DBMET01125 | DBMET01125 | |
| 0.023 | 0.508 | 0.284 | Electrolyte absorption antagonist | 0.142 0.023 DBMET00023 0.177 0.012 DBMET01126 0.154 0.018 DBMET01125 0.284 0.004 DBMET01146 | DBMET01146 | |
| 0.007 | 0.493 | 0.053 | Integrin alpha2 antagonist | 0.053 0.01 DBMET01146 | DBMET01146 | |
| 0.01 | 0.496 | 0.055 | AICAR transformylase inhibitor | 0.049 0.023 DBMET00023 0.049 0.024 DBMET01126 0.055 0.017 DBMET01146 | DBMET01146 | |
| 0.011 | 0.501 | 0.25 | Alcohol dehydrogenase inhibitor | 0.25 0.008 DBMET00023 0.116 0.038 DBMET01126 0.127 0.03 DBMET01125 0.135 0.026 DBMET01146 | DBMET00023 | |
| 0.002 | 0.492 | 0.022 | NMDA receptor glycine site antagonist | 0.022 0.019 DBMET01146 | DBMET01146 | |
| 0.004 | 0.5 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET01126 0.021 0.013 DBMET01125 0.025 0.007 DBMET01146 | DBMET01146 | |
| 0.03 | 0.526 | 0.47 | Peroxidase inhibitor | 0.25 0.047 DBMET00023 0.22 0.054 DBMET01126 0.323 0.033 DBMET01125 0.47 0.012 DBMET01146 | DBMET01146 | |
| 0.008 | 0.509 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.013 DBMET01126 0.04 0.014 DBMET01146 | DBMET01126 | |
| 0.028 | 0.536 | 0.189 | Cyclooxygenase 3 inhibitor | 0.118 0.08 DBMET01126 0.102 0.101 DBMET01125 0.189 0.023 DBMET01146 | DBMET01146 | |
| 0.009 | 0.517 | 0.1 | Adenylate cyclase 1 inhibitor | 0.09 0.005 DBMET01126 0.076 0.009 DBMET01125 0.1 0.004 DBMET01146 | DBMET01146 | |
| 0.023 | 0.534 | 0.102 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET01126 0.082 0.04 DBMET01125 0.102 0.012 DBMET01146 | DBMET01146 | |
| 0.015 | 0.526 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 DBMET01146 | DBMET01146 | |
| 0.017 | 0.531 | 0.102 | GABA B receptor agonist | 0.071 0.064 DBMET00023 0.086 0.032 DBMET01125 0.102 0.015 DBMET01146 | DBMET01146 | |
| 0.009 | 0.525 | 0.069 | Retinoid X alpha receptor antagonist | 0.037 0.018 DBMET01126 0.069 0.003 DBMET01146 | DBMET01146 | |
| 0.037 | 0.552 | 0.377 | 3C-like protease (Human coronavirus) inhibitor | 0.377 0.004 DBMET00023 0.257 0.024 DBMET01126 0.27 0.019 DBMET01125 0.15 0.1 DBMET01146 | DBMET00023 | |
| 0.041 | 0.561 | 0.262 | Neurotrophic factor enhancer | 0.147 0.143 DBMET00023 0.169 0.111 DBMET01126 0.262 0.032 DBMET01146 | DBMET01146 | |
| 0.008 | 0.529 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.048 DBMET01146 | DBMET01146 | |
| 0.004 | 0.528 | 0.043 | Carbonic anhydrase VII inhibitor | 0.043 0.036 DBMET01146 | DBMET01146 | |
| 0.005 | 0.529 | 0.105 | NMDA receptor glycine site agonist | 0.075 0.032 DBMET01125 0.105 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.527 | 0.039 | Prostaglandin H2 antagonist | 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.005 | 0.532 | 0.039 | Nerve growth factor antagonist | 0.039 0.038 DBMET00023 | DBMET00023 | |
| 0.005 | 0.533 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 DBMET01125 | DBMET01125 | |
| 0.009 | 0.54 | 0.079 | Retinoid X receptor antagonist | 0.042 0.021 DBMET01126 0.079 0.003 DBMET01146 | DBMET01146 | |
| 0.014 | 0.547 | 0.098 | Dihydroorotate oxidase inhibitor | 0.055 0.038 DBMET00023 0.084 0.009 DBMET01126 0.098 0.005 DBMET01146 | DBMET01146 | |
| 0.011 | 0.548 | 0.04 | Vanilloid 3 antagonist | 0.04 0.023 DBMET01146 | DBMET01146 | |
| 0.004 | 0.542 | 0.022 | CXC chemokine 5 receptor antagonist | 0.022 0.007 DBMET01146 | DBMET01146 | |
| 0.062 | 0.599 | 0.37 | Calcium channel activator | 0.255 0.142 DBMET00023 0.311 0.081 DBMET01126 0.327 0.067 DBMET01125 0.37 0.038 DBMET01146 | DBMET01146 | |
| 0.003 | 0.541 | 0.064 | Dihydropteroate synthase inhibitor | 0.039 0.028 DBMET01126 0.064 0.01 DBMET01146 | DBMET01146 | |
| 0.004 | 0.541 | 0.027 | MAP3K8 inhibitor | 0.027 0.025 DBMET01125 | DBMET01125 | |
| 0.001 | 0.54 | 0.044 | Prostaglandin EP4 agonist | 0.044 0.005 DBMET01146 | DBMET01146 | |
| 0.015 | 0.556 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | 0.038 0.026 DBMET01125 | DBMET01125 | |
| 0.004 | 0.549 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.032 0.006 DBMET01146 | DBMET01146 | |
| 0.004 | 0.55 | 0.058 | ATP citrate lysase inhibitor | 0.058 0.005 DBMET01146 | DBMET01146 | |
| 0.004 | 0.554 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.02 DBMET01126 0.039 0.022 DBMET01146 | DBMET01126 | |
| 0.008 | 0.559 | 0.878 | Epidermal growth factor antagonist | 0.833 0.003 DBMET00658 0.738 0.004 DBMET01088 0.878 0.003 DBMET01123 0.115 0.035 DBMET01126 0.75 0.004 DBMET01147 0.101 0.044 DBMET01125 0.143 0.025 DBMET01146 | DBMET01123 | |
| 0.011 | 0.563 | 0.078 | Interferon agonist | 0.073 0.065 DBMET01125 0.078 0.056 DBMET01146 | DBMET01146 | |
| 0.018 | 0.57 | 0.151 | Exportin-1 inhibitor | 0.091 0.014 DBMET00023 0.142 0.004 DBMET01126 0.074 0.035 DBMET01125 0.151 0.003 DBMET01146 | DBMET01146 | |
| 0.057 | 0.609 | 0.157 | Catenin beta inhibitor | 0.157 0.091 DBMET01146 | DBMET01146 | |
| 0.011 | 0.564 | 0.071 | Pregnane X receptor antagonist | 0.065 0.022 DBMET00023 0.066 0.02 DBMET01126 0.055 0.045 DBMET01125 0.071 0.013 DBMET01146 | DBMET01146 | |
| 0.007 | 0.562 | 0.031 | Complement factor 1s inhibitor | 0.031 0.007 DBMET01126 0.027 0.014 DBMET01146 | DBMET01126 | |
| 0.009 | 0.565 | 0.146 | NMDA receptor agonist | 0.079 0.029 DBMET01125 0.146 0.009 DBMET01146 | DBMET01146 | |
| 0.015 | 0.573 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 DBMET01125 | DBMET01125 | |
| 0.002 | 0.563 | 0.069 | 5-Alpha-reductase inhibitor | 0.069 0.014 DBMET01146 | DBMET01146 | |
| 0.003 | 0.564 | 0.047 | Nicotinic acid receptor 2 antagonist | 0.035 0.008 DBMET01126 0.047 0.004 DBMET01146 | DBMET01146 | |
| 0.017 | 0.579 | 0.243 | Telomerase inhibitor | 0.243 0.01 DBMET01125 | DBMET01125 | |
| 0.012 | 0.575 | 0.063 | Interferon inducer | 0.061 0.051 DBMET01125 0.063 0.047 DBMET01146 | DBMET01146 | |
| 0.006 | 0.569 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 DBMET01126 | DBMET01126 | |
| 0.01 | 0.574 | 0.041 | Potassium channel Kv1.1 blocker | 0.041 0.021 DBMET01126 0.035 0.033 DBMET01125 | DBMET01126 | |
| 0.011 | 0.577 | 0.069 | Glutamate (mGluR4) antagonist | 0.04 0.038 DBMET01125 0.069 0.01 DBMET01146 | DBMET01146 | |
| 0.021 | 0.587 | 0.196 | Adenylate cyclase inhibitor | 0.109 0.077 DBMET01126 0.196 0.026 DBMET01146 | DBMET01146 | |
| 0.004 | 0.572 | 0.088 | Caspase 2 inhibitor | 0.088 0.005 DBMET00023 | DBMET00023 | |
| 0.024 | 0.592 | 0.555 | Aldehyde oxidase inhibitor | 0.34 0.057 DBMET00023 0.279 0.072 DBMET01126 0.295 0.068 DBMET01125 0.555 0.025 DBMET01146 | DBMET01146 | |
| 0.02 | 0.589 | 0.095 | Phosphodiesterase I inhibitor | 0.095 0.052 DBMET01125 | DBMET01125 | |
| 0.069 | 0.639 | 0.731 | Caspase 9 stimulant | 0.296 0.198 DBMET00023 0.491 0.063 DBMET01126 0.284 0.212 DBMET01125 0.731 0.02 DBMET01146 | DBMET01146 | |
| 0.038 | 0.608 | 0.519 | Superoxide dismutase inhibitor | 0.407 0.025 DBMET00023 0.519 0.011 DBMET01126 0.358 0.035 DBMET01125 0.498 0.013 DBMET01146 | DBMET01126 | |
| 0.014 | 0.584 | 0.152 | Caspase 3 inhibitor | 0.152 0.027 DBMET00023 0.139 0.037 DBMET00658 0.143 0.033 DBMET01088 0.104 0.085 DBMET01123 0.135 0.041 DBMET01126 0.119 0.061 DBMET01125 0.147 0.03 DBMET01146 | DBMET00023 | |
| 0.006 | 0.576 | 0.11 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 DBMET00023 0.11 0.024 DBMET01126 0.096 0.035 DBMET01125 0.086 0.044 DBMET01146 | DBMET01126 | |
| 0.027 | 0.603 | 0.339 | Melanin inhibitor | 0.156 0.073 DBMET00023 0.339 0.017 DBMET01126 0.259 0.027 DBMET01146 | DBMET01126 | |
| 0.009 | 0.586 | 0.062 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.056 0.034 DBMET01126 0.062 0.028 DBMET01146 | DBMET01146 | |
| 0.036 | 0.615 | 0.105 | Glutamate release inhibitor | 0.093 0.056 DBMET00023 0.099 0.043 DBMET01125 0.105 0.036 DBMET01146 | DBMET01146 | |
| 0.01 | 0.59 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.079 0.028 DBMET00023 0.095 0.018 DBMET01126 0.068 0.04 DBMET01146 | DBMET01126 | |
| 0.023 | 0.606 | 0.124 | Carbonic anhydrase XV inhibitor | 0.124 0.043 DBMET01125 0.102 0.064 DBMET01146 | DBMET01125 | |
| 0.011 | 0.594 | 0.087 | 5 Hydroxytryptamine 3 agonist | 0.087 0.022 DBMET01126 0.066 0.04 DBMET01146 | DBMET01126 | |
| 0.017 | 0.606 | 0.173 | Proteasome inhibitor | 0.173 0.035 DBMET00023 0.167 0.037 DBMET01126 0.133 0.056 DBMET01125 0.116 0.069 DBMET01146 | DBMET00023 | |
| 0.035 | 0.628 | 0.577 | Cholesterol antagonist | 0.25 0.125 DBMET00023 0.32 0.079 DBMET01126 0.241 0.132 DBMET01125 0.577 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.595 | 0.016 | 5-Alpha-reductase 1 inhibitor | 0.016 0.013 DBMET01146 | DBMET01146 | |
| 0.003 | 0.597 | 0.027 | 5-Alpha-reductase 2 inhibitor | 0.027 0.01 DBMET01146 | DBMET01146 | |
| 0.001 | 0.599 | 0.045 | Prostaglandin EP2 agonist | 0.045 0.007 DBMET01146 | DBMET01146 | |
| 0.004 | 0.602 | 0.045 | GABA B receptor antagonist | 0.045 0.026 DBMET01146 | DBMET01146 | |
| 0.008 | 0.607 | 0.135 | CYP2A6 inhibitor | 0.069 0.06 DBMET00023 0.135 0.021 DBMET01126 0.075 0.053 DBMET01125 0.089 0.042 DBMET01146 | DBMET01126 | |
| 0.005 | 0.606 | 0.05 | Leukotriene C4 antagonist | 0.05 0.011 DBMET01146 | DBMET01146 | |
| 0.007 | 0.609 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 DBMET01125 0.052 0.045 DBMET01146 | DBMET01125 | |
| 0.005 | 0.608 | 0.053 | AMPA 4 receptor antagonist | 0.053 0.013 DBMET01146 | DBMET01146 | |
| 0.018 | 0.621 | 0.259 | HIV-1 integrase (Overall Integration) inhibitor | 0.129 0.035 DBMET01126 0.259 0.005 DBMET01146 | DBMET01146 | |
| 0.008 | 0.613 | 0.06 | Glutamate (mGluR group III) agonist | 0.06 0.018 DBMET01146 | DBMET01146 | |
| 0.014 | 0.62 | 0.074 | CD45 antagonist | 0.074 0.014 DBMET01146 | DBMET01146 | |
| 0.025 | 0.634 | 0.284 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.136 DBMET00023 0.155 0.138 DBMET01126 0.168 0.112 DBMET01125 0.284 0.029 DBMET01146 | DBMET01146 | |
| 0.011 | 0.62 | 0.123 | Carbonic anhydrase XIII inhibitor | 0.067 0.062 DBMET00023 0.088 0.044 DBMET01126 0.123 0.028 DBMET01146 | DBMET01146 | |
| 0.002 | 0.611 | 0.11 | Kainate receptor 2 antagonist | 0.04 0.022 DBMET01126 0.11 0.004 DBMET01146 | DBMET01146 | |
| 0.008 | 0.618 | 0.069 | Carbonic anhydrase stimulant | 0.055 0.046 DBMET01125 0.069 0.032 DBMET01146 | DBMET01146 | |
| 0.018 | 0.632 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 DBMET01125 | DBMET01125 | |
| 0.005 | 0.621 | 0.094 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET01126 0.094 0.004 DBMET01146 | DBMET01146 | |
| 0.021 | 0.638 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.036 DBMET01126 0.064 0.042 DBMET01146 | DBMET01126 | |
| 0.013 | 0.63 | 0.149 | Sphingosine 1-phosphate receptor 2 antagonist | 0.149 0.043 DBMET01125 0.148 0.043 DBMET01146 | DBMET01125 | |
| 0.005 | 0.622 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.054 0.029 DBMET01146 | DBMET01146 | |
| 0.017 | 0.635 | 0.616 | Thioredoxin glutathione reductase inhibitor | 0.616 0.014 DBMET00023 0.51 0.027 DBMET01125 | DBMET00023 | |
| 0.004 | 0.622 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 DBMET01146 | DBMET01146 | |
| 0.019 | 0.638 | 0.285 | 5 Hydroxytryptamine 1E antagonist | 0.285 0.04 DBMET01126 0.211 0.118 DBMET01125 0.251 0.074 DBMET01146 | DBMET01126 | |
| 0.033 | 0.653 | 0.084 | CC chemokine 5 receptor agonist | 0.082 0.057 DBMET01126 0.084 0.052 DBMET01125 0.08 0.066 DBMET01146 | DBMET01125 | |
| 0.009 | 0.63 | 0.062 | Glutamate (mGluR group III) antagonist | 0.062 0.012 DBMET01146 | DBMET01146 | |
| 0.018 | 0.641 | 0.17 | Carbonic anhydrase III inhibitor | 0.17 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.624 | 0.018 | G-protein-coupled receptor 120 agonist | 0.018 0.011 DBMET01146 | DBMET01146 | |
| 0.006 | 0.63 | 0.073 | Leukotriene C antagonist | 0.073 0.012 DBMET01146 | DBMET01146 | |
| 0.028 | 0.658 | 0.308 | Interleukin agonist | 0.164 0.154 DBMET01126 0.2 0.121 DBMET01125 0.308 0.044 DBMET01146 | DBMET01146 | |
| 0.002 | 0.633 | 0.046 | Diamine oxidase inhibitor | 0.046 0.017 DBMET01146 | DBMET01146 | |
| 0.001 | 0.631 | 0.065 | Kainate receptor 1 antagonist | 0.065 0.005 DBMET01146 | DBMET01146 | |
| 0.005 | 0.636 | 0.038 | Glutamate (mGluR4) agonist | 0.038 0.018 DBMET01146 | DBMET01146 | |
| 0.023 | 0.656 | 0.218 | Cyclic AMP phosphodiesterase inhibitor | 0.218 0.081 DBMET01125 0.202 0.092 DBMET01146 | DBMET01125 | |
| 0.008 | 0.64 | 0.096 | Sphingosine 1-phosphate receptor antagonist | 0.096 0.024 DBMET01125 | DBMET01125 | |
| 0.005 | 0.64 | 0.071 | Metalloproteinase-2 inhibitor | 0.071 0.064 DBMET01146 | DBMET01146 | |
| 0.025 | 0.661 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.096 DBMET01125 0.158 0.049 DBMET01146 | DBMET01146 | |
| 0.008 | 0.645 | 0.099 | Glutamate (mGluR7) antagonist | 0.073 0.037 DBMET00023 0.073 0.038 DBMET01126 0.099 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.641 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.01 DBMET01146 | DBMET01146 | |
| 0.01 | 0.649 | 0.193 | Prostaglandin dehydrogenase inhibitor | 0.193 0.161 DBMET01146 | DBMET01146 | |
| 0.009 | 0.651 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.054 DBMET01125 | DBMET01125 | |
| 0.011 | 0.657 | 0.316 | DNA intercalator | 0.316 0.011 DBMET01125 | DBMET01125 | |
| 0.021 | 0.67 | 0.217 | Photosensitizer | 0.102 0.085 DBMET00023 0.15 0.031 DBMET01126 0.097 0.094 DBMET01125 0.217 0.01 DBMET01146 | DBMET01146 | |
| 0.013 | 0.663 | 0.366 | Spasmolytic | 0.314 0.065 DBMET01125 0.366 0.048 DBMET01146 | DBMET01146 | |
| 0.013 | 0.669 | 0.113 | Alpha 2b adrenoreceptor antagonist | 0.113 0.064 DBMET01125 | DBMET01125 | |
| 0.014 | 0.671 | 0.134 | Carbonic anhydrase VI inhibitor | 0.073 0.068 DBMET01125 0.134 0.025 DBMET01146 | DBMET01146 | |
| 0.012 | 0.669 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET01146 | DBMET01146 | |
| 0.002 | 0.662 | 0.063 | Oleamide hydrolase inhibitor | 0.045 0.032 DBMET00023 0.043 0.034 DBMET01126 0.063 0.019 DBMET01125 | DBMET01125 | |
| 0.016 | 0.676 | 0.312 | Aldehyde dehydrogenase inhibitor | 0.195 0.029 DBMET00023 0.312 0.01 DBMET01126 0.27 0.015 DBMET01146 | DBMET01126 | |
| 0.002 | 0.666 | 0.112 | Kainate receptor antagonist | 0.112 0.006 DBMET01146 | DBMET01146 | |
| 0.029 | 0.694 | 0.2 | Neurotensin receptor agonist | 0.159 0.081 DBMET00023 0.14 0.129 DBMET01126 0.2 0.035 DBMET01125 0.2 0.034 DBMET01146 | DBMET01146 | |
| 0.003 | 0.668 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 DBMET01146 | DBMET01146 | |
| 0.002 | 0.668 | 0.03 | HCV NS5B polymerase inhibitor | 0.03 0.023 DBMET01146 | DBMET01146 | |
| 0.002 | 0.671 | 0.04 | Free fatty acid receptor 1 antagonist | 0.04 0.016 DBMET01146 | DBMET01146 | |
| 0.003 | 0.672 | 0.055 | NMDA receptor subunit 3B antagonist | 0.055 0.022 DBMET01146 | DBMET01146 | |
| 0.024 | 0.694 | 0.272 | Interferon gamma antagonist | 0.135 0.101 DBMET00023 0.18 0.05 DBMET01126 0.272 0.024 DBMET01146 | DBMET01146 | |
| 0.001 | 0.671 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 DBMET01146 | DBMET01146 | |
| 0.002 | 0.673 | 0.045 | NMDA receptor subunit 3A antagonist | 0.045 0.022 DBMET01146 | DBMET01146 | |
| 0.019 | 0.691 | 0.135 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 DBMET01126 0.094 0.066 DBMET01125 0.135 0.018 DBMET01146 | DBMET01146 | |
| 0.012 | 0.687 | 0.134 | Acetylcholine M1 receptor antagonist | 0.134 0.091 DBMET01125 | DBMET01125 | |
| 0.009 | 0.686 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 DBMET01125 | DBMET01125 | |
| 0.004 | 0.681 | 0.092 | Amidase inhibitor | 0.079 0.038 DBMET00023 0.092 0.029 DBMET01126 | DBMET01126 | |
| 0.005 | 0.682 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.039 DBMET01125 | DBMET01125 | |
| 0.007 | 0.685 | 0.061 | Heparanase inhibitor | 0.061 0.021 DBMET01146 | DBMET01146 | |
| 0.002 | 0.681 | 0.057 | Kynurenine 3 monooxygenase inhibitor | 0.057 0.005 DBMET01146 | DBMET01146 | |
| 0.003 | 0.684 | 0.096 | Leukotriene B4 antagonist | 0.096 0.011 DBMET01146 | DBMET01146 | |
| 0.007 | 0.688 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.023 DBMET01146 | DBMET01146 | |
| 0.003 | 0.686 | 0.053 | NMDA 2A receptor antagonist | 0.053 0.035 DBMET01146 | DBMET01146 | |
| 0.002 | 0.686 | 0.041 | AMPA 3 receptor antagonist | 0.041 0.013 DBMET01146 | DBMET01146 | |
| 0.016 | 0.703 | 0.121 | Vanilloid agonist | 0.121 0.018 DBMET01146 | DBMET01146 | |
| 0.005 | 0.694 | 0.117 | Acetylcholine M2 receptor agonist | 0.117 0.005 DBMET01076 | DBMET01076 | |
| 0.058 | 0.748 | 0.277 | Heat shock protein 70 antagonist | 0.157 0.032 DBMET01126 0.13 0.123 DBMET01125 0.277 0.004 DBMET01146 | DBMET01146 | |
| 0.04 | 0.731 | 0.441 | 5 Hydroxytryptamine release inhibitor | 0.327 0.136 DBMET00023 0.295 0.17 DBMET01126 0.344 0.121 DBMET01125 0.441 0.056 DBMET01146 | DBMET01146 | |
| 0.015 | 0.706 | 0.523 | Transcription factor NF kappa B inhibitor | 0.289 0.1 DBMET00023 0.468 0.049 DBMET01126 0.263 0.118 DBMET01125 0.523 0.041 DBMET01146 | DBMET01146 | |
| 0.002 | 0.694 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 DBMET01126 0.041 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.696 | 0.065 | Aromatase inhibitor | 0.065 0.038 DBMET01126 | DBMET01126 | |
| 0.005 | 0.7 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.013 DBMET01146 | DBMET01146 | |
| 0.003 | 0.7 | 0.077 | Nicotinic acid receptor agonist | 0.077 0.007 DBMET01146 | DBMET01146 | |
| 0.005 | 0.702 | 0.076 | Alpha adrenoreceptor antagonist | 0.076 0.075 DBMET01125 | DBMET01125 | |
| 0.003 | 0.7 | 0.041 | Dihydrofolate reductase inhibitor | 0.041 0.036 DBMET01146 | DBMET01146 | |
| 0.008 | 0.705 | 0.156 | Falcipain 3 inhibitor | 0.14 0.041 DBMET00023 0.156 0.034 DBMET01126 0.094 0.077 DBMET01125 | DBMET01126 | |
| 0.001 | 0.698 | 0.046 | Prostaglandin E2 agonist | 0.046 0.006 DBMET01146 | DBMET01146 | |
| 0.002 | 0.701 | 0.079 | Prostaglandin agonist | 0.079 0.007 DBMET01146 | DBMET01146 | |
| 0.003 | 0.703 | 0.06 | Potassium channel Kv1.3 blocker | 0.06 0.021 DBMET01126 0.059 0.022 DBMET01146 | DBMET01126 | |
| 0.002 | 0.703 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET01146 | DBMET01146 | |
| 0.004 | 0.707 | 0.031 | Trypsin II inhibitor | 0.031 0.019 DBMET00023 | DBMET00023 | |
| 0.007 | 0.71 | 0.279 | Calpain inhibitor | 0.279 0.042 DBMET00023 0.236 0.078 DBMET01126 0.22 0.094 DBMET01125 | DBMET00023 | |
| 0.004 | 0.709 | 0.048 | Factor XIIIa inhibitor | 0.04 0.023 DBMET01126 0.048 0.017 DBMET01146 | DBMET01146 | |
| 0.014 | 0.725 | 0.107 | Acetylcholine release stimulant | 0.106 0.074 DBMET01126 0.107 0.071 DBMET01146 | DBMET01146 | |
| 0.005 | 0.718 | 0.18 | Cytidine deaminase inhibitor | 0.155 0.071 DBMET01126 0.18 0.057 DBMET01146 | DBMET01146 | |
| 0.003 | 0.72 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.027 DBMET01146 | DBMET01146 | |
| 0.001 | 0.727 | 0.054 | Peroxisome proliferator-activated receptor delta agonist | 0.054 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.73 | 0.076 | NMDA receptor antagonist | 0.076 0.07 DBMET01146 | DBMET01146 | |
| 0.001 | 0.729 | 0.027 | AMPA 1 receptor antagonist | 0.027 0.022 DBMET01146 | DBMET01146 | |
| 0.002 | 0.732 | 0.079 | Thromboxane A2 antagonist | 0.079 0.015 DBMET01146 | DBMET01146 | |
| 0.005 | 0.738 | 0.145 | Anesthetic local | 0.145 0.051 DBMET01126 0.132 0.058 DBMET01146 | DBMET01126 | |
| 0.004 | 0.74 | 0.184 | Psychostimulant | 0.184 0.09 DBMET01146 | DBMET01146 | |
| 0.005 | 0.741 | 0.091 | Androgen antagonist | 0.091 0.054 DBMET00023 0.089 0.056 DBMET01125 0.077 0.069 DBMET01146 | DBMET00023 | |
| 0.002 | 0.741 | 0.03 | Liver X receptor beta antagonist | 0.03 0.019 DBMET01146 | DBMET01146 | |
| 0.006 | 0.745 | 0.419 | Calpain 2 inhibitor | 0.419 0.051 DBMET00023 0.318 0.103 DBMET01126 0.282 0.126 DBMET01125 | DBMET00023 | |
| 0.008 | 0.747 | 0.077 | Myeloperoxidase inhibitor | 0.077 0.073 DBMET01125 | DBMET01125 | |
| 0.015 | 0.757 | 0.075 | Antineoplastic alkaloid | 0.075 0.073 DBMET01146 | DBMET01146 | |
| 0.011 | 0.752 | 0.203 | Thiol protease inhibitor | 0.189 0.043 DBMET00023 0.203 0.038 DBMET01126 0.137 0.085 DBMET01125 0.165 0.057 DBMET01146 | DBMET01126 | |
| 0.022 | 0.764 | 0.185 | CF transmembrane conductance regulator agonist | 0.134 0.108 DBMET00023 0.184 0.033 DBMET01126 0.135 0.106 DBMET01125 0.185 0.032 DBMET01146 | DBMET01146 | |
| 0.005 | 0.748 | 0.051 | Glucosylceramidase inhibitor | 0.051 0.045 DBMET01126 | DBMET01126 | |
| 0.003 | 0.751 | 0.058 | Cathepsin L inhibitor | 0.058 0.041 DBMET00023 | DBMET00023 | |
| 0.008 | 0.757 | 0.099 | AMP-activated protein kinase stimulant | 0.099 0.072 DBMET01146 | DBMET01146 | |
| 0.003 | 0.753 | 0.085 | Thromboxane antagonist | 0.085 0.017 DBMET01146 | DBMET01146 | |
| 0.012 | 0.763 | 0.112 | Bile acid receptor antagonist | 0.112 0.028 DBMET01146 | DBMET01146 | |
| 0.003 | 0.755 | 0.074 | Cannabinoid CB2 receptor antagonist | 0.074 0.022 DBMET01125 | DBMET01125 | |
| 0.002 | 0.755 | 0.032 | LFA antagonist | 0.032 0.013 DBMET01146 | DBMET01146 | |
| 0.003 | 0.757 | 0.045 | RNA-directed RNA polymerase inhibitor | 0.045 0.015 DBMET01146 | DBMET01146 | |
| 0.01 | 0.764 | 0.134 | Pregnane X receptor agonist | 0.127 0.107 DBMET01126 0.134 0.089 DBMET01146 | DBMET01146 | |
| 0.004 | 0.761 | 0.209 | Phospholipase A2 inhibitor | 0.209 0.038 DBMET01146 | DBMET01146 | |
| 0.002 | 0.763 | 0.09 | Squalene synthetase inhibitor | 0.09 0.007 DBMET01146 | DBMET01146 | |
| 0.002 | 0.763 | 0.068 | Peroxisome proliferator-activated receptor alpha agonist | 0.068 0.023 DBMET01146 | DBMET01146 | |
| 0.003 | 0.767 | 0.21 | Monophenol monooxygenase inhibitor | 0.095 0.08 DBMET01126 0.21 0.031 DBMET01146 | DBMET01146 | |
| 0.006 | 0.773 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 DBMET01146 | DBMET01146 | |
| 0.003 | 0.771 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.027 DBMET01146 | DBMET01146 | |
| 0.002 | 0.771 | 0.052 | Cannabinoid CB1 receptor agonist | 0.052 0.051 DBMET01125 | DBMET01125 | |
| 0.001 | 0.771 | 0.036 | Progesterone antagonist | 0.036 0.025 DBMET01146 | DBMET01146 | |
| 0.006 | 0.777 | 0.193 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.193 0.104 DBMET01146 | DBMET01146 | |
| 0.003 | 0.775 | 0.029 | ICAM 1 antagonist | 0.029 0.007 DBMET01146 | DBMET01146 | |
| 0.01 | 0.785 | 0.154 | Interleukin 8 antagonist | 0.154 0.032 DBMET01146 | DBMET01146 | |
| 0.004 | 0.779 | 0.041 | Melatonin 2 agonist | 0.041 0.015 DBMET01125 | DBMET01125 | |
| 0.02 | 0.795 | 0.357 | Insulysin inhibitor | 0.192 0.169 DBMET00023 0.284 0.069 DBMET01126 0.228 0.119 DBMET01125 0.357 0.032 DBMET01146 | DBMET01146 | |
| 0.002 | 0.779 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET01146 | DBMET01146 | |
| 0.005 | 0.783 | 0.095 | Caspase 7 inhibitor | 0.095 0.034 DBMET00023 0.092 0.038 DBMET01126 0.081 0.058 DBMET01146 | DBMET00023 | |
| 0.002 | 0.781 | 0.044 | Angiotensin AT1 receptor antagonist | 0.044 0.026 DBMET01146 | DBMET01146 | |
| 0.019 | 0.799 | 0.297 | Cyclophilin D inhibitor | 0.297 0.166 DBMET01146 | DBMET01146 | |
| 0.01 | 0.791 | 0.16 | Antibacterial (Helicobacter pylori) | 0.16 0.039 DBMET01125 0.133 0.063 DBMET01146 | DBMET01125 | |
| 0.018 | 0.801 | 0.162 | Hexokinase inhibitor | 0.143 0.087 DBMET00023 0.162 0.065 DBMET01126 0.158 0.07 DBMET01146 | DBMET01126 | |
| 0.011 | 0.793 | 0.467 | Antithrombotic | 0.276 0.106 DBMET00023 0.326 0.074 DBMET01126 0.191 0.189 DBMET01125 0.467 0.034 DBMET01146 | DBMET01146 | |
| 0.013 | 0.799 | 0.261 | Hypoxia-inducible factor 1 alpha inhibitor | 0.261 0.09 DBMET00023 0.209 0.141 DBMET01126 0.209 0.142 DBMET01125 0.23 0.119 DBMET01146 | DBMET00023 | |
| 0.005 | 0.791 | 0.126 | Alkaline phosphatase inhibitor | 0.126 0.079 DBMET01146 | DBMET01146 | |
| 0.005 | 0.795 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.048 DBMET01146 | DBMET01146 | |
| 0.006 | 0.796 | 0.063 | Cyclin D1 inhibitor | 0.063 0.039 DBMET01126 | DBMET01126 | |
| 0.001 | 0.796 | 0.042 | Urate transporter 1 inhibitor | 0.042 0.024 DBMET01146 | DBMET01146 | |
| 0.009 | 0.805 | 0.154 | Xanthine oxidase inhibitor | 0.095 0.064 DBMET01126 0.154 0.033 DBMET01146 | DBMET01146 | |
| 0.005 | 0.802 | 0.102 | Plasminogen activator inhibitor | 0.064 0.036 DBMET00019 0.102 0.015 DBMET00023 | DBMET00023 | |
| 0.013 | 0.811 | 0.113 | Phosphodiesterase 6D inhibitor | 0.089 0.077 DBMET01126 0.113 0.032 DBMET01146 | DBMET01146 | |
| 0.019 | 0.817 | 0.145 | MAP kinase 3 inhibitor | 0.129 0.109 DBMET01126 0.145 0.076 DBMET01146 | DBMET01146 | |
| 0.003 | 0.801 | 0.079 | Thromboxane synthase inhibitor | 0.079 0.012 DBMET01146 | DBMET01146 | |
| 0.008 | 0.808 | 0.086 | MDM2 inhibitor | 0.086 0.014 DBMET01146 | DBMET01146 | |
| 0.005 | 0.811 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.126 0.031 DBMET00023 0.136 0.024 DBMET01126 0.084 0.083 DBMET01125 0.136 0.024 DBMET01146 | DBMET01146 | |
| 0.004 | 0.81 | 0.035 | Caspase 6 inhibitor | 0.035 0.013 DBMET00023 | DBMET00023 | |
| 0.013 | 0.819 | 0.167 | NADPH oxidase inhibitor | 0.163 0.047 DBMET00023 0.167 0.045 DBMET01126 0.114 0.091 DBMET01146 | DBMET01126 | |
| 0.022 | 0.829 | 0.518 | Histamine release inhibitor | 0.255 0.152 DBMET01126 0.518 0.023 DBMET01146 | DBMET01146 | |
| 0.01 | 0.819 | 0.055 | Sodium/calcium exchanger inhibitor | 0.055 0.025 DBMET01125 | DBMET01125 | |
| 0.004 | 0.813 | 0.132 | Macrophage migration inhibitory factor inhibitor | 0.132 0.021 DBMET01146 | DBMET01146 | |
| 0.007 | 0.818 | 0.103 | Beta glucuronidase inhibitor | 0.103 0.066 DBMET01126 0.09 0.088 DBMET01146 | DBMET01126 | |
| 0.002 | 0.814 | 0.093 | Xanthine dehydrogenase inhibitor | 0.093 0.018 DBMET01126 0.093 0.018 DBMET01146 | DBMET01146 | |
| 0.003 | 0.816 | 0.072 | Adrenaline agonist | 0.072 0.068 DBMET01125 | DBMET01125 | |
| 0.002 | 0.815 | 0.106 | Leukotriene antagonist | 0.106 0.019 DBMET01146 | DBMET01146 | |
| 0.003 | 0.818 | 0.341 | TRPA1 antagonist | 0.077 0.027 DBMET00023 0.341 0.004 DBMET01126 | DBMET01126 | |
| 0.004 | 0.824 | 0.112 | Beta amyloid protein antagonist | 0.112 0.076 DBMET01146 | DBMET01146 | |
| 0.02 | 0.841 | 0.144 | Transcription factor NF kappa B stimulant | 0.082 0.066 DBMET01126 0.144 0.017 DBMET01146 | DBMET01146 | |
| 0.003 | 0.828 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DBMET01125 | DBMET01125 | |
| 0.004 | 0.832 | 0.297 | Pyruvate kinase inhibitor | 0.201 0.08 DBMET01126 0.297 0.048 DBMET01146 | DBMET01146 | |
| 0.01 | 0.838 | 0.058 | Factor III inhibitor | 0.058 0.02 DBMET01146 | DBMET01146 | |
| 0.001 | 0.832 | 0.036 | Prostaglandin EP4 antagonist | 0.036 0.012 DBMET01146 | DBMET01146 | |
| 0.016 | 0.847 | 0.349 | Gastrin inhibitor | 0.22 0.119 DBMET01126 0.204 0.143 DBMET01125 0.349 0.011 DBMET01146 | DBMET01146 | |
| 0.005 | 0.838 | 0.14 | Neuropeptide Y1 antagonist | 0.14 0.082 DBMET01125 | DBMET01125 | |
| 0.013 | 0.847 | 0.484 | Vasodilator, peripheral | 0.207 0.168 DBMET01126 0.199 0.177 DBMET01125 0.484 0.031 DBMET01146 | DBMET01146 | |
| 0.011 | 0.846 | 0.273 | ATPase inhibitor | 0.177 0.062 DBMET00023 0.273 0.009 DBMET01126 0.141 0.118 DBMET01125 0.241 0.016 DBMET01146 | DBMET01126 | |
| 0.015 | 0.849 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 DBMET01146 | DBMET01146 | |
| 0.003 | 0.843 | 0.064 | Cannabinoid receptor antagonist | 0.064 0.057 DBMET01125 | DBMET01125 | |
| 0.004 | 0.844 | 0.112 | MAP kinase kinase 1 inhibitor | 0.112 0.043 DBMET01146 | DBMET01146 | |
| 0.003 | 0.845 | 0.083 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.03 DBMET01146 | DBMET01146 | |
| 0.013 | 0.859 | 0.201 | Histone acetyltransferase inhibitor | 0.169 0.114 DBMET00023 0.201 0.068 DBMET01125 | DBMET01125 | |
| 0.003 | 0.855 | 0.095 | Inducible nitric-oxide synthase inhibitor | 0.079 0.064 DBMET01125 0.095 0.041 DBMET01146 | DBMET01146 | |
| 0.005 | 0.864 | 0.235 | Transcription factor STAT3 inhibitor | 0.235 0.096 DBMET01126 0.217 0.114 DBMET01146 | DBMET01126 | |
| 0.003 | 0.864 | 0.082 | Antineoplastic antibiotic | 0.078 0.058 DBMET01126 0.082 0.056 DBMET01146 | DBMET01146 | |
| 0.002 | 0.863 | 0.049 | Liver X receptor alpha agonist | 0.049 0.02 DBMET01146 | DBMET01146 | |
| 0.007 | 0.874 | 0.232 | Cell wall synthesis inhibitor | 0.137 0.078 DBMET01126 0.232 0.02 DBMET01146 | DBMET01146 | |
| 0.009 | 0.877 | 0.272 | Chymotrypsin inhibitor | 0.272 0.005 DBMET00023 0.116 0.027 DBMET01126 0.094 0.04 DBMET01125 | DBMET00023 | |
| 0.008 | 0.883 | 0.247 | DNA methylase inhibitor | 0.247 0.05 DBMET01146 | DBMET01146 | |
| 0.005 | 0.88 | 0.565 | Topoisomerase II alpha inhibitor | 0.17 0.02 DBMET00023 0.565 0.004 DBMET01125 | DBMET01125 | |
| 0 | 0.878 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.008 DBMET01126 | DBMET01126 | |
| 0.009 | 0.89 | 0.122 | CDK3/cyclin E inhibitor | 0.122 0.053 DBMET01125 | DBMET01125 | |
| 0.003 | 0.884 | 0.11 | MAP kinase kinase inhibitor | 0.11 0.084 DBMET01146 | DBMET01146 | |
| 0.004 | 0.886 | 0.294 | Insulin sensitizer | 0.158 0.123 DBMET01126 0.294 0.017 DBMET01146 | DBMET01146 | |
| 0.003 | 0.886 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.061 DBMET01126 0.091 0.076 DBMET01125 0.09 0.078 DBMET01146 | DBMET01126 | |
| 0.005 | 0.891 | 0.203 | Transcription factor STAT inhibitor | 0.203 0.134 DBMET01126 0.194 0.148 DBMET01146 | DBMET01126 | |
| 0.003 | 0.894 | 0.231 | 12-Lipoxygenase inhibitor | 0.19 0.162 DBMET01126 0.231 0.121 DBMET01146 | DBMET01146 | |
| 0.004 | 0.894 | 0.141 | Mediator release inhibitor | 0.141 0.033 DBMET01146 | DBMET01146 | |
| 0.003 | 0.902 | 0.274 | Cyclin-dependent kinase 5 inhibitor | 0.201 0.022 DBMET00023 0.274 0.012 DBMET01125 | DBMET01125 | |
| 0.006 | 0.906 | 0.266 | DNA methyltransferase I inhibitor | 0.139 0.117 DBMET01126 0.266 0.04 DBMET01146 | DBMET01146 | |
| 0.007 | 0.917 | 0.05 | Glutamate (mGluR8) antagonist | 0.05 0.008 DBMET01146 | DBMET01146 | |
| 0.004 | 0.915 | 0.238 | Non-steroidal antiinflammatory agent | 0.177 0.09 DBMET01126 0.238 0.048 DBMET01146 | DBMET01146 | |
| 0.004 | 0.925 | 0.38 | Antibacterial | 0.219 0.208 DBMET00023 0.375 0.088 DBMET01126 0.38 0.086 DBMET01146 | DBMET01146 | |
| 0.003 | 0.924 | 0.179 | Diuretic | 0.179 0.054 DBMET01146 | DBMET01146 | |
| 0.003 | 0.929 | 0.272 | 15-Lipoxygenase inhibitor | 0.272 0.148 DBMET01146 | DBMET01146 | |
| 0.003 | 0.932 | 0.109 | Gastric antisecretory | 0.109 0.055 DBMET01146 | DBMET01146 | |
| 0.004 | 0.934 | 0.518 | Growth factor antagonist | 0.348 0.022 DBMET00658 0.243 0.036 DBMET01088 0.518 0.01 DBMET01123 0.194 0.048 DBMET01147 | DBMET01123 | |
| 0.005 | 0.936 | 0.122 | Hemostatic | 0.122 0.11 DBMET01146 | DBMET01146 | |
| 0.006 | 0.942 | 0.133 | Tumour necrosis factor antagonist | 0.133 0.122 DBMET01126 | DBMET01126 | |
| 0.002 | 0.941 | 0.253 | Lipoxygenase inhibitor | 0.253 0.098 DBMET01146 | DBMET01146 | |
| 0.035 | 0.983 | 0.349 | Peptidyltransferase inhibitor | 0.215 0.081 DBMET01126 0.349 0.012 DBMET01125 0.329 0.016 DBMET01146 | DBMET01125 | |
| 0.008 | 0.961 | 0.061 | Integrin alpha1beta1 antagonist | 0.061 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.956 | 0.118 | Plasmin inhibitor | 0.118 0.014 DBMET00023 0.088 0.02 DBMET01126 | DBMET00023 | |
| 0.004 | 0.958 | 0.132 | Antipruritic | 0.132 0.118 DBMET01146 | DBMET01146 | |
| 0.002 | 0.957 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 DBMET00019 | DBMET00019 | |
| 0.019 | 0.978 | 0.182 | Lipocortins synthesis antagonist | 0.182 0.069 DBMET01146 | DBMET01146 | |
| 0 | 0.96 | 0.012 | Calcineurin inhibitor | 0.012 0.007 DBMET01146 | DBMET01146 | |
| 0.029 | 0.99 | 0.172 | ErbB-1 antagonist | 0.172 0.13 DBMET01126 0.166 0.141 DBMET01146 | DBMET01126 | |
| 0.01 | 0.974 | 0.395 | 3C-Like protease (SARS coronavirus) inhibitor | 0.395 0.003 DBMET00023 0.08 0.069 DBMET00658 0.324 0.003 DBMET01126 | DBMET00023 | |
| 0.008 | 0.974 | 0.056 | Cathepsin E inhibitor | 0.056 0.047 DBMET01146 | DBMET01146 | |
| 0.004 | 0.97 | 0.144 | Estrogen antagonist | 0.144 0.026 DBMET01146 | DBMET01146 | |
| 0.006 | 0.975 | 0.169 | Acetylcholine M3 receptor agonist | 0.169 0.011 DBMET01076 | DBMET01076 | |
| 0.014 | 0.982 | 0.09 | Folate antagonist | 0.09 0.086 DBMET01146 | DBMET01146 | |
| 0.004 | 0.973 | 0.08 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.078 DBMET01146 | DBMET01146 | |
| 0.02 | 0.992 | 0.331 | Interleukin 2 agonist | 0.331 0.055 DBMET01146 | DBMET01146 | |
| 0.006 | 0.981 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 DBMET01146 | DBMET01146 | |
| 0.003 | 0.979 | 0.057 | Neuraminidase inhibitor | 0.057 0.047 DBMET01146 | DBMET01146 | |
| 0.009 | 0.988 | 0.061 | Prolactin release inhibitor | 0.061 0.049 DBMET01146 | DBMET01146 | |
| 0.003 | 0.983 | 0.116 | Protein 50S ribosomal subunit inhibitor | 0.095 0.014 DBMET00023 0.116 0.01 DBMET01126 | DBMET01126 | |
| 0.004 | 0.983 | 0.06 | Human rhinovirus A protease inhibitor | 0.06 0.035 DBMET00023 | DBMET00023 | |
| 0.001 | 0.981 | 0.024 | Integrin beta3 antagonist | 0.024 0.011 DBMET01146 | DBMET01146 | |
| 0.002 | 0.982 | 0.243 | Bruton tyrosine kinase inhibitor | 0.243 0.005 DBMET01126 0.133 0.009 DBMET01146 | DBMET01126 | |
| 0.002 | 0.982 | 0.045 | HMG CoA reductase inhibitor | 0.045 0.01 DBMET01146 | DBMET01146 | |
| 0.012 | 0.993 | 0.358 | Factor V inhibitor | 0.358 0.001 DBMET00023 0.176 0.01 DBMET00658 0.332 0.001 DBMET01126 | DBMET00023 | |
| 0.007 | 0.988 | 0.055 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.05 DBMET01125 | DBMET01125 | |
| 0.003 | 0.986 | 0.246 | Antiadrenergic | 0.246 0.018 DBMET01125 | DBMET01125 | |
| 0.002 | 0.985 | 0.276 | Calpain 1 inhibitor | 0.276 0.002 DBMET00023 0.2 0.003 DBMET01126 | DBMET00023 | |
| 0.004 | 0.987 | 0.443 | Topoisomerase II inhibitor | 0.443 0.008 DBMET01125 | DBMET01125 | |
| 0.003 | 0.987 | 0.22 | Adrenaline antagonist | 0.22 0.02 DBMET01125 | DBMET01125 | |
| 0.004 | 0.988 | 0.393 | Antioxidant | 0.235 0.092 DBMET01088 0.169 0.144 DBMET01123 0.256 0.08 DBMET01126 0.393 0.036 DBMET01146 | DBMET01146 | |
| 0.009 | 0.993 | 0.389 | ABCA1 expression enhancer | 0.191 0.01 DBMET00023 0.128 0.026 DBMET01126 0.389 0.004 DBMET01146 | DBMET01146 | |
| 0.012 | 0.996 | 0.134 | Papain-like protease (SARS coronavirus) inhibitor | 0.134 0.053 DBMET01126 0.124 0.072 DBMET01146 | DBMET01126 | |
| 0.01 | 0.996 | 0.336 | Growth hormone agonist | 0.336 0.025 DBMET01146 | DBMET01146 | |
| 0.009 | 0.995 | 0.339 | Sodium/bile acid cotransporter inhibitor | 0.339 0.047 DBMET01146 | DBMET01146 | |
| 0.007 | 0.995 | 0.086 | Ca(v)3.1 blocker | 0.086 0.044 DBMET01126 | DBMET01126 | |
| 0.004 | 0.991 | 0.155 | Chelator | 0.155 0.034 DBMET01146 | DBMET01146 | |
| 0.003 | 0.992 | 0.193 | Tubulin antagonist | 0.193 0.039 DBMET01125 | DBMET01125 | |
| 0.002 | 0.991 | 0.137 | CDK4/cyclin D1 inhibitor | 0.137 0.008 DBMET01126 | DBMET01126 | |
| 0.004 | 0.993 | 0.238 | Insulin secretagoues | 0.238 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.99 | 0.191 | ErbB-4 antagonist | 0.149 0.021 DBMET01126 0.191 0.014 DBMET01146 | DBMET01146 | |
| 0.003 | 0.992 | 0.445 | MAP3K7 inhibitor | 0.065 0.063 DBMET01126 0.445 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.991 | 0.077 | CDK4/cyclin D inhibitor | 0.077 0.023 DBMET01126 | DBMET01126 | |
| 0.004 | 0.993 | 0.238 | Vasodilator | 0.238 0.076 DBMET01126 0.23 0.082 DBMET01146 | DBMET01126 | |
| 0.003 | 0.992 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.041 DBMET01146 | DBMET01146 | |
| 0.004 | 0.993 | 0.33 | Free radical scavenger | 0.221 0.082 DBMET01126 0.33 0.044 DBMET01146 | DBMET01146 | |
| 0.004 | 0.994 | 0.281 | Angiogenesis stimulant | 0.281 0.056 DBMET01146 | DBMET01146 | |
| 0.001 | 0.992 | 0.038 | Leukotriene B4 receptor 2 antagonist | 0.038 0.005 DBMET01146 | DBMET01146 | |
| 0.005 | 0.996 | 0.87 | Caspase 3 stimulant | 0.252 0.11 DBMET00023 0.87 0.003 DBMET01126 0.277 0.091 DBMET01125 0.378 0.051 DBMET01146 | DBMET01126 | |
| 0.005 | 0.996 | 0.083 | DNA helicase inhibitor | 0.083 0.01 DBMET01146 | DBMET01146 | |
| 0.004 | 0.995 | 0.186 | ErbB-3 antagonist | 0.128 0.026 DBMET01126 0.186 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.994 | 0.089 | Estrogen receptor beta antagonist | 0.089 0.085 DBMET01146 | DBMET01146 | |
| 0.006 | 0.998 | 0.585 | NOS3 expression enhancer | 0.205 0.039 DBMET01126 0.585 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.098 | Thrombin inhibitor | 0.098 0.027 DBMET00023 | DBMET00023 | |
| 0.003 | 0.995 | 0.372 | Antimitotic | 0.372 0.028 DBMET01125 | DBMET01125 | |
| 0.004 | 0.996 | 0.478 | Platelet adhesion inhibitor | 0.478 0.006 DBMET01126 0.325 0.026 DBMET01146 | DBMET01126 | |
| 0.003 | 0.995 | 0.19 | Thrombolytic | 0.19 0.057 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.349 | Hypolipemic | 0.349 0.035 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.121 | Factor XII inhibitor | 0.121 0.023 DBMET00023 0.078 0.07 DBMET01126 | DBMET00023 | |
| 0.003 | 0.995 | 0.113 | Protease inhibitor | 0.113 0.054 DBMET00023 0.096 0.069 DBMET01126 | DBMET00023 | |
| 0.003 | 0.995 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.027 DBMET01076 | DBMET01076 | |
| 0.003 | 0.995 | 0.193 | VCAM-1 antagonist | 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.193 | VCAM antagonist | 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.994 | 0.06 | Prostaglandin D2 agonist | 0.06 0.005 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.388 | Hypoglycemic | 0.198 0.115 DBMET01126 0.388 0.03 DBMET01146 | DBMET01146 | |
| 0.002 | 0.995 | 0.228 | Cathepsin B inhibitor | 0.228 0.004 DBMET00023 0.188 0.005 DBMET01126 | DBMET00023 | |
| 0.003 | 0.996 | 0.089 | Prostaglandin F2 alpha antagonist | 0.089 0.016 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.479 | EphB2 antagonist | 0.479 0.008 DBMET01146 | DBMET01146 | |
| 0.002 | 0.995 | 0.094 | Lipase inhibitor | 0.094 0.031 DBMET01126 | DBMET01126 | |
| 0.002 | 0.995 | 0.265 | Protein-tyrosine phosphatase 1B inhibitor | 0.265 0.014 DBMET01146 | DBMET01146 | |
| 0.003 | 0.997 | 0.111 | Caspase 9 inhibitor | 0.107 0.012 DBMET00023 0.111 0.011 DBMET01126 0.063 0.041 DBMET01146 | DBMET01126 | |
| 0.002 | 0.995 | 0.434 | Prostaglandin EP2 antagonist | 0.434 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.372 | Apoptosis antagonist | 0.316 0.075 DBMET01126 0.372 0.047 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.061 | Trypsin inhibitor | 0.061 0.045 DBMET01126 | DBMET01126 | |
| 0.001 | 0.995 | 0.074 | Retinoic acid gamma receptor agonist | 0.074 0.003 DBMET01146 | DBMET01146 | |
| 0 | 0.994 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET01126 | DBMET01126 | |
| 0.003 | 0.996 | 0.454 | Platelet antagonist | 0.454 0.019 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.047 | GP IIb/IIIa receptor antagonist | 0.047 0.035 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.493 | Nitric oxide antagonist | 0.493 0.016 DBMET01126 0.42 0.023 DBMET01146 | DBMET01126 | |
| 0.002 | 0.996 | 0.146 | Retinoic acid alpha receptor agonist | 0.146 0.003 DBMET01146 | DBMET01146 | |
| 0.003 | 0.997 | 0.373 | Interleukin 6 antagonist | 0.373 0.009 DBMET01146 | DBMET01146 | |
| 0.003 | 0.997 | 0.041 | HCV polyprotein inhibitor | 0.041 0.011 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.234 | Tumour necrosis factor alpha release inhibitor | 0.234 0.083 DBMET01146 | DBMET01146 | |
| 0 | 0.995 | 0.037 | 3C-Like protease (MERS coronavirus) inhibitor | 0.037 0.002 DBMET00023 0.036 0.002 DBMET01126 | DBMET00023 | |
| 0.002 | 0.996 | 0.122 | HIV-1 integrase inhibitor | 0.122 0.014 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.096 | Elastase 1 inhibitor | 0.096 0.023 DBMET01126 | DBMET01126 | |
| 0.002 | 0.996 | 0.323 | Protein-tyrosine phosphatase inhibitor | 0.323 0.015 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.061 | Sirtuin 1 inhibitor | 0.061 0.058 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.104 | Retinoic acid beta receptor agonist | 0.104 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.185 | Retinoid X gamma receptor agonist | 0.185 0.002 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.293 | Retinoid X beta receptor agonist | 0.293 0.002 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.134 | CDC25A inhibitor | 0.134 0.015 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.112 | Cell adhesion molecule inhibitor | 0.112 0.027 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.099 | Aldose reductase inhibitor | 0.099 0.018 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.295 | Interleukin antagonist | 0.295 0.049 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.104 | Fibroblast growth factor 4 antagonist | 0.104 0.008 DBMET01126 0.074 0.023 DBMET01146 | DBMET01126 | |
| 0.002 | 0.997 | 0.229 | Interleukin 1 antagonist | 0.229 0.023 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.025 | Cathepsin K inhibitor | 0.025 0.021 DBMET00023 | DBMET00023 | |
| 0.001 | 0.996 | 0.02 | Prostaglandin EP1 antagonist | 0.02 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.083 | Integrin antagonist | 0.083 0.019 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.033 | Integrin beta5 antagonist | 0.033 0.008 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.105 | Selectin antagonist | 0.105 0.026 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.128 | Retinoic acid receptor agonist | 0.128 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.093 | Falcipain inhibitor | 0.093 0.06 DBMET01126 | DBMET01126 | |
| 0.001 | 0.996 | 0.106 | Retinoid X gamma receptor antagonist | 0.106 0.001 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.239 | Cell adhesion inhibitor | 0.239 0.016 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.13 | Lipid peroxidase inhibitor | 0.13 0.083 DBMET01146 | DBMET01146 | |
| 0.002 | 0.998 | 0.158 | Interleukin 4 antagonist | 0.122 0.083 DBMET01126 0.158 0.043 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.026 | Vitronectin receptor antagonist | 0.026 0.012 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.111 | HIV-1 integrase (3'-Processing) inhibitor | 0.111 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.088 | CDC25B inhibitor | 0.076 0.031 DBMET01126 0.088 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.097 | Prostaglandin E2 antagonist | 0.097 0.015 DBMET01146 | DBMET01146 | |
| 0 | 0.996 | 0.086 | Retinoic acid alpha receptor antagonist | 0.086 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.095 | Transcription factor AP-1 inhibitor | 0.095 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.133 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET01126 0.133 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.033 | Prostacyclin agonist | 0.033 0.005 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.05 | VLA-4 antagonist | 0.05 0.013 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.173 | Peroxisome proliferator-activated receptor gamma agonist | 0.173 0.009 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.213 | Prostaglandin antagonist | 0.213 0.006 DBMET01146 | DBMET01146 | |
| 0 | 0.996 | 0.035 | Retinoic acid receptor gamma antagonist | 0.035 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.183 | Uric acid excretion stimulant | 0.09 0.065 DBMET01126 0.183 0.016 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.109 | Leukotriene B4 receptor 1 antagonist | 0.109 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.075 | Prostacyclin antagonist | 0.075 0.006 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.026 | NMDA 2D receptor antagonist | 0.026 0.02 DBMET01146 | DBMET01146 | |
| 0.002 | 0.998 | 0.218 | Interleukin 1b antagonist | 0.218 0.016 DBMET01146 | DBMET01146 | |
| 0 | 0.996 | 0.04 | Retinoic acid beta receptor antagonist | 0.04 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.091 | Leukotriene synthesis inhibitor | 0.091 0.031 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.082 | Retinoic acid receptor antagonist | 0.082 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.06 | Plasminogen activator inhibitor antagonist | 0.06 0.024 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.058 | Prostaglandin D2 antagonist | 0.058 0.006 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.163 | Amyloid beta precursor protein antagonist | 0.163 0.087 DBMET01126 | DBMET01126 | |
| 0.001 | 0.997 | 0.024 | Free fatty acid receptor 1 agonist | 0.024 0.008 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.161 | Prostaglandin EP3 antagonist | 0.161 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.096 | 5-Lipoxygenase inhibitor | 0.096 0.067 DBMET01146 | DBMET01146 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |